Cytokine Catch-And-Release Communication Enables Long-Term Response To Transient Inflammation by Oyler, Jennifer
CYTOKINE CATCH-AND-RELEASE COMMUNICATION ENABLES
LONG-TERM RESPONSE TO TRANSIENT INFLAMMATION
A Dissertation
Presented to the Faculty of the Weill Cornell Graduate School
of Medical Sciences
in Partial Fulfillment of the Requirements for the Degree of
Doctor of Philosophy
by
Jennifer Erin Oyler
August 2016
© 2016 Jennifer Erin Oyler
CYTOKINE CATCH-AND-RELEASE COMMUNICATION ENABLES
LONG-TERM RESPONSE TO TRANSIENT INFLAMMATION
Jennifer Erin Oyler, Ph.D.
Cornell University 2016
In every biological system, individual cells must adapt to ever-changing envi-
ronments in order to survive. To adapt, cells translate extra-cellular cues, into
phenotypic changes. In the mammalian immune system, cells sample the envi-
ronment for pathogens or tumors, and secrete cytokines to alert other cells of the
threat. Genome-wide profiling techniques have been instrumental to determine the
identity of genes that change in response to cytokines. Often these experiments
profile mRNA before and after cytokine stimulation at a single time-point. While
single time-point experiments are ideal for identifying which genes changed in re-
sponse to a cytokine, studies of gene expression changes over time - dynamics -
can reveal novel mechanisms of gene regulation. In vivo, cytokines are often se-
creted transiently (hours), yet the dynamics of an acute immune response occur
over a week. These widely varied timescales pose a question: how do cells translate
short-lived cytokine exposure into long-term gene expression changes that persist
for the duration of an immune response? More fundamentally, what mechanisms
exist to regulate the duration of a cells? response to a transient stimulus? We
studied the transcriptional dynamics of cells exposed to a brief pulse of the cy-
tokine Interferon γ and observed long-term up-regulation of genes in the antigen
processing and presentation pathway. Transcription of these genes persisted over
a timescale of 2 days, before slowly decaying after about one week. By combining
mathematical modeling with a variety of experimental techniques, we learned that
IFNγ is captured by cell surface exposed phosphatidylserine on viable cells. The
cytokine is then slowly released to drive persistent transcription of IFNγ-response
genes in both an autocrine and paracrine manner. Ultimately, this enables a tran-
siently produced cytokine to act over a timescale much longer than that of its
secretion. This mechanism is a novel mode of cell-to-cell communication, which
we coined catch-and-release communication. We observed that catch-and-release
communication is a general phenomenon of cell-to-cell communication as it is ap-
plicable also to the cytokines Interleukin 12 and 23, and can be executed by diverse
cell types from multiple different species. Functionally, catch-and-release signaling
could enable cells separated by both space and time to communicate with one
another.
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CHAPTER 1
INTRODUCTION
In every biological system, individual cells must adapt to ever-changing environ-
ments in order to survive. To adapt, cells respond to extra-cellular cues, which
are translated into phenotypic changes. In the mammalian immune system, cells
constantly sample the environment for potential pathogens or tumors, and then
secrete small molecules called cytokines to alert surrounding cells of the threat.
Many different cytokines exist which serve to communicate the particular immune
context. For example, viral versus bacterial infections necessitate different cellular
responses, thus different cytokines will be produced. Different cytokine cocktails
elicit variable gene expression responses. Therefore diverse cell functions can be
engineered based on the diversity of cytokines in the microenvironment. Indeed,
a major focus of work has been deciphering which genes change in response to
specific cytokines.
Genome-wide profiling techniques have been instrumental in determining the
identity of genes that change in response to specific cytokines [14, 15]. Often these
experiments profile mRNA derived from animal tissue or cultured cells before and
after cytokine stimulation at a single timepoint. In addition, a great deal has been
learned from experiments analyzing gene expression patterns in animals or humans
that are deficient for components of cytokine signaling pathways [3, 18, 37, 65].
While these single, snapshot-type experiments are ideal for identifying which genes
changed in response to a cytokine, studies of gene expression changes over time,
dynamics, can reveal novel mechanisms of gene regulation [30, 31, 55, 68, 84].
Studying transcriptional dynamics has been a useful strategy to learn what gen-
eral principles regulate gene expression. In a series of studies, cells were exposed
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to a consistent source of the pro-inflammatory cytokine tumor necrosis factor α
(TNFα), and RNA was harvested periodically and analyzed by either microarray
or RT-qPCR [30, 31]. Examination of the gene expression kinetics revealed dis-
tinct waves of transcription with clusters of genes peaking in expression at early,
intermediate, or late timepoints. The authors performed a series of experiments
which proved that the basis for this clustering was largely inherent to the DNA and
RNA code. Specifically, the time required for processing of pre-mRNA into mature
mRNA (splicing rate) and the mature mRNA stability (biochemical degradation
rate) were critical parameters controlling the transcriptional dynamics. The era of
genome-wide studies and an appreciation for the importance of studying how sys-
tems change over time, have added complexity to datasets. This has necessitated
the development of computational tools that make it easier (or even possible), to
distill key features from large, multi-dimensional datasets.
In some cases, simple mathematical models can be useful tools that reveal
insights that would otherwise be difficult or impossible to glean from complex
datasets. For example, Rabani et al. implemented a mathematical model that did
not assume that gene regulatory rates are constant with time [67, 68]. In other
words, for a given gene, the rates of transcription, splicing, and mRNA degradation
may change with time. A consequence of this is that a single transcriptional tempo-
ral pattern is achieved from many different regulatory strategies [68]. What is the
purpose of using different strategies to achieve the same trajectory of gene expres-
sion? This question is ideally-suited for analysis with a mathematical model where
testing of multiple hypotheses is quick, easy, and not subject to the constraints
of what is experimentally possible. Simulations revealed that despite the ability
of different regulatory strategies to achieve the same pattern of transcription, dif-
ferent strategies may have different functional roles. For instance, by increasing
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all three rates (transcription, splicing, and degradation), a transcript achieves a
similar temporal profile as a simple increase in transcription rate, yet in the former
case, the level of gene expression is more robust to a noisy input signal compared
to the latter.
Up-stream of gene expression, extracellular cues are encoded by signaling molecules
and transcription factors. These molecules initiate intracellular signaling relays,
ultimately resulting in changes in cell phenotype. The strategy of combining math-
ematical modeling with time-course experiments has proven especially fruitful for
dissecting gene regulatory mechanisms from the kinetics of transcription factor ac-
tivation. For example, signaling molecules can exhibit diverse dynamical patterns
that drive variable kinetics of gene expression [10, 33, 46, 58, 59, 62, 66, 82, 85].
To take a classic example, Cai et al. studied the nuclear localization dynamics
of the yeast transcription factor Crz1 in response to different doses of extracellular
calcium [10]. The frequency of Crz1 nuclear localization was directly proportional
to the calcium concentration. This was a novel way for cells to intracellularly
encode the concentration of an extracellular stimulus. Traditionally, cells were
thought to primarily encode the stimulus dose by tuning the amplitude of response
or concentration of active transcription factor. To explore the functional signifi-
cance of this, the authors used a mathematical model that compared expression
of different genes given either amplitude or frequency modulation as a regulatory
strategy. The model predicted that frequency modulation would enable cells to
coordinate expression of different signal-response genes across variable stimulus
doses. The authors tested this prediction experimentally and found that, indeed,
frequency modulation of Crz1 localization enabled genes to be expressed propor-
tionally across variable calcium doses, despite different promoter architecture.
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These conclusions would have been impossible but for an experiment that
tracked signaling dynamics and implementation of a model that generated a testable
prediction. Understanding the myriad ways that healthy cells translate extracel-
lular cues into phenotypic changes allows us to more clearly identify dysfunctional
signaling in diseases like cancer [29]. In addition studying dynamics can have
immediate practical implications.
In a recent example, tracking the signaling dynamics of the tumor suppres-
sor p53 enabled identification of the optimal timing for administration of DNA
damage to maximize tumor cell death [12]. The obvious goal of chemotherapy
is to maximize killing of tumor cells, while sparing healthy cells. However, one
major challenge of this goal is that upon administration of the drug, there are
often subsets of cancer cells which survive. The authors hypothesized that by first
sensitizing the tumor cells with a drug, they may be able to increase the tumors’
susceptibility to subsequent administration of another drug. They discovered that
following inhibition of the p53 suppressor MDMX, cells undergo an initial burst
of p53 nuclear localization, followed by several periods of p53 nuclear-cytoplasmic
oscillation. If a DNA damaging drug was applied during the early p53 burst, nearly
all of the tumor cells died. In stark contrast, if the drug was applied during the os-
cillatory phase, nearly all of the tumor cells survived. The authors attributed this
to different gene expression profiles during the p53 burst and oscillatory states.
This observation argues that the timing of drug administration is a critical pa-
rameter that ought to be included when clinicians decide upon drug dosage and
potential combination therapies.
In similar example, Lee et al. investigated the effectiveness of treating triple
negative breast cancer cell lines with sequential application of first an epidermal
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growth factor receptor inhibitor (erlotinib), followed by a DNA damaging drug
[45]. Erlotinib alone was only modestly effective in killing the cells, and adding
the DNA damaging agent 30 minutes after erlotinib did not enhance cytotoxicity.
However, when cells were sensitized for a day with erlotinib, then subjected to DNA
damage, cytotoxicity increased dramatically. The authors examined the changes in
the signaling and gene expression network over time after erlotinib administration
and noticed that the tumor cells slowly adopted a more ”normal” phenotype and
lost canonical oncogenic signatures. To parse the high-dimensional dataset they
generated, the authors used linear models such as principle component analysis and
partial least squares regression. Their models pointed to the importance of the pro-
apoptotic gene caspase-8 in mediating cell death after erlotinib treatment. Indeed,
when they knocked down caspase-8 prior to EGFR inhibition, DNA damage was
less effective in killing the cells. Again, the authors would have not identified this
drug synergy had they not investigated dynamics. In addition, the mechanism
of caspase-8 activation would have been difficult to pinpoint without a model to
reduce the complexity of their high-dimensional dataset.
DNA damaging agents such as chemotherapeutic drugs and/or radiation for
cancer treatment have been joined recently by small molecule inhibitors designed
to target specific pathways that are dysregulated in tumors. More recently, the
immune system has been recognized as holding tremendous potential in the fight
against cancer if it can be ”unleashed” upon the tumor. Indeed, immunotherapeu-
tics have been demonstrated to cause dramatic and durable remission in certain
cancer subsets [27, 43, 64, 81]. Given that the timing and order of chemothera-
peutic and small molecule inhibitor administration can be optimized [12, 45], we
speculated that there is also an optimal timing for immunotherapeutic intervention
after tumor exposure to pro-inflammatory cytokines.
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The pro-inflammatory cytokine Interferonγ (IFNγ) is produced by activated
immune cells, such as T cells and Natural Killer cells [73]. T cells scan host
cells via T cell receptor (TCR) binding to peptides presented by either major
histocompatibility complex class I or II (MHC-I or -II) on host cells. T cells are
tolerized to self-peptides, but can become activated if their TCR binds to mutated
or over-expressed self peptides (in the case of cancer), or pathogen-derived peptides.
When a TCR binds strongly to peptide-MHC, it physically arrests, initiates a
signaling cascade that results in gene expression changes, and secretes cytokines
including IFNγ [34]. T cells and peptide-presenting host cells remain in physical
contact for several hours while T cells secrete cytokines. After several hours, T
cells up-regulate inhibitory molecules, causing them to dissociate from the host
cells and cease cytokine production. Another group has more rigorously quantified
the timescale of cytokine production [32]. In a population of T cells, the IFNγ
production period follows a log normal distribution where cells secrete cytokine
for 5.9 ± 3.6 hours after activation. It is worth noting that these several hours of
cytokine secretion represent only a minuscule window of an overall acute immune
response, which occurs over the timescale of approximately a week.
Mice and humans deficient for IFNγ signaling exhibit profound susceptibility
to viruses, parasites, and bacteria. In addition, IFNγ prevents primary tumor
development and improves rejection of established tumors [16, 78]. Across diverse
human cancers, the presence of an IFNγ gene signature is a positive prognostic
marker [49]. Importantly, after exposure to IFNγ, cells are better able to be
recognized and killed by T cells, indicating that the cytokine ”primes” cells for
subsequent T cell encounter.
The timescale over which cells maintain a phenotypic change after exposure to
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a transient signal can span several orders of magnitude (Figure 1.1).
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Figure 1.1: Timescales of phenotypic change after exposure to transient
stimulus. In the simplest model of signal-induced gene up-regulation (a, blue),
the timescale of gene up-regulation essentially tracks the presence of the external
signal. Stabilization of mRNA would modestly lengthen the time required for gene
expression to return to background levels, but would not change the peak time
(b, red) [20]. Gene expression can change indefinitely in response to a transient
signal resulting in cell differentiation (d, purple). This can be caused by an epi-
genetic change that chemically or structurally modifies the chromatin leading to
sustained gene expression in the absence of the original signal [2]. Alternatively,
positive feedback can trigger a switch that irreversibly alters the cell phenotype
[39]. Mechanisms promoting an intermediate phenotype, where cells can amplify
their timing of signal response past the timescale of the signal, but still return to
their original cell state are understudied (c, green).
Given the most basic model of gene regulation (a, blue), the cells’ response would
essentially track the external stimulus. Once the signal is abrogated, the cell would
rapidly return to its original phenotypic state. A mechanism that slows mRNA
decay would modestly extend the time before a cell reached its original state, but
ultimately the timescale of gene expression would coincide with the timescale of
the signal (b, red) [20]. At the other end of the spectrum, chromatin modifications
can stabilize gene expression in response to a signal such that the phenotypic
change persists indefinitely (d, purple) [2]. Alternatively, phenotypic changes can
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be maintained by biochemical switches caused by positive feedback [39]. How
though, can cells achieve an intermediate response (c, green)? In this scheme, cells
can extend their period of gene expression past the timescale of signal exposure, but
retain the ability to return to return to their original phenotypic state. Examples
of intermediate timescales of signal response are rare in the literature.
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CHAPTER 2
IN THIS DISSERTATION
Given that IFNγ is secreted transiently (hours), yet is crucial for host-pathogen
or host-tumor defense over long timescales (days/weeks), we sought to determine
the temporal duration of a cells response to brief IFNγ exposure. Furthermore, we
asked what regulatory strategies control how long a cell responds to IFNγ. The
aims generated by these two over-arching questions will be outlined in the next
section.
2.1 Aims
1. Determine the timing after IFNγ exposure when melanoma cells best activate
T cells.
2. Quantify the temporal duration of the cell gene expression response to tran-
sient IFNγ.
3. Characterize the gene expression signature of melanoma cells following tran-
sient exposure to IFNγ.
4. Identify the molecular mechanism(s) that regulate the temporal duration of
the melanoma response to transient IFNγ.
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CHAPTER 3
A MINIMAL MODEL OF GENE EXPRESSION BASED ON THE
CENTRAL DOGMA OF BIOLOGY.
We introduce a minimal model for the cell response to an external stimulus.
The kinetics of the reaction can be summarized as:
dX
dt
= k(t)− β ·X, (3.1)
where X(t) is a cell response (i.e. mRNA level) as a function of time, k(t) is the
response rate (transcription rate), and β is the constant molecular decay rate for
the response.
We introduce a binary signal at time t = 0 and remove it at time t = t0. Under
the simplest assumptions, the transcription rate changes with the introduction of
the signal, and returns to its original baseline value once the signal is removed
(Figure 3.1):
k(t) =

k0 if 0 < t
k1 if 0 < t < t0
k0 if t0 < t
. (3.2)
The resulting dynamics ofX is an exponential approach while the signal is supplied,
followed by an exponential decay back to its baseline (Figure 3.1):
X(t) =

k0
β
(baseline value) if t < 0
k0
β
+ k1−k0
β
(
1− e−βt) if 0 < t < t0
k0
β
+ k1−k0
β
(
1− e−βt0) e−β(t−t0) for t0 < t
(3.3)
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Notice that while a decrease in the molecular decay rate β might prolong the signal,
the functional form of transcriptional dynamics remains unchanged. Response
increases while the signal is supplied, peaks when the signal is removed, and decays
back to the baseline after. In this system, there is only a single timescale which is
set by the molecular decay rate, β.
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Figure 3.1: Exposure to a transient signal given the simplest model of
gene expression. The transcription factor is expected to change instantaneously
in response to the signal. The transcriptional response is expected to follow an
exponential approach following application of signal, and to degrade exponentially
back to the steady state level after removal of the signal.
3.1 Specifying the model for the IFNγ response.
We begin our model of transcription with the central dogma of molecular biol-
ogy: DNA is transcribed into mRNA at a rate ktranscription, and mRNA chemically
degrades over time. This is summarized in the equation:
d[mRNA]
dt
= kbasaltranscription − [mRNA] · kdecay, (3.4)
The steady state
(
d[mRNA]
dt
= 0
)
concentration of mRNA in the system is [mRNA]ss =
kbasaltranscription
kdecay
.
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The effect of IFNγ on transcription is introduced by the transcription factor
STAT1. When IFNγ binds to its receptor, STAT1 is phosphorylated by Janus
Kinase (JAK), dimerizes, and translocates to the nucleus. These processes are
summarized by the following set of equations,

d[IFNγRc]
dt
= kon · [IFNγR] · [IFNγ]− koff · [IFNγRc],
d[IFNγR]
dt
= −d[IFNγRc]
dt
,
d[pSTAT1]
dt
= kphos · [STAT1] · [IFNγRc]− kdeg · [pSTAT1],
d[STAT1]
dt
= −d[pSTAT1]
dt
,
(3.5)
where IFNγR is the IFNγ receptor, IFNγRc is the complex of IFNγ and its recep-
tor, kon and koff are the kinetic on- and off- rates of the IFNγRc complex formation,
and kphos and kdeg are the STAT1 phosphorylation and degradation rates.
Experimentally, we checked that STAT1 phosphorylation occurs rapidly upon
exposure of the cells to IFNγ (Figure 3.2a), reaching a steady state within minutes.
Following treatment with a JAK inhibitor, pSTAT1 levels in the system rapidly
return to baseline levels (Figure 3.2b).
Given that the timescale of transcription is on the order of hours-days compared
to the timescale of signaling (seconds-minutes), for simplicity, the dynamics of
STAT1 phosphorylation and dephosphorylation are assumed to reach steady state
instantaneously.
Using conservation:
IFNγRtotal = IFNγR + IFNγRc,
STAT1total = STAT1 + pSTAT1,
(3.6)
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(a) pSTAT1 signaling rapidly
reaches steady-state after cell
exposure to IFNγ. B16 cells were
exposed to either media alone, or 1nM
IFNγ. Cells were harvested at indicated
timepoints, fixed and permeabilized,
and stained for phosphorylated STAT1
protein. Fluorescence was quantified by
flow cytometry.
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(b) pSTAT1 signaling rapidly re-
turns to baseline upon administra-
tion of a JAK inhibitor. Cells were
stimulated with 10nM IFNγ, then 10µM
of the JAK1/2 inhibitor AZD1480 was
added. Cells were harvested at indi-
cated timepoints, fixed and permeabi-
lized, and stained for pSTAT1. The
data were fit with a double exponen-
tial decay function with the decay rates
for each exponent as fitting parameters.
Data plotted is the mean and s.e.m. (er-
rorbars) and representative of 3 inde-
pendent experiments.
Figure 3.2: Timescales of the pSTAT1 response to signals.
where IFNγRtotal, and STAT1total are the total levels of IFNγ receptor and STAT1,
respectively.
From these equations, we calculate the steady-state of IFNγRc and pSTAT1
for a given dose of IFNγ:
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IFNγRc = IFNγRtotal
kon · [IFNγ]
(kon · [IFNγ]) + koff ∝
1
1 + KD
[IFNγ]
pSTAT1 =
[IFNγRtotal][STAT1total]kphoskon
[IFNγRtotal]konkphos + kdegkon
 [IFNγ]
[IFNγ] +
kdegkoff
[IFNγRtotal]konkphos+kdegkon

∝ 1
1 + EC50
[IFNγ]
,
(3.7)
where Kd =
koff
kon
. The dose dependance of pSTAT1 on IFNγ concentrations is
expected to follow a Hill function with coefficient 1. (Figure 7.25a) shows that
cells indeed follow such a dose response curve with EC50 ≈ 3pM:
pSTAT1([IFNγ]) ∝ 1
1 + EC50
[IFNγ]
. (3.8)
3.2 Linking transcription factor activation with transcrip-
tion.
Next, we will explore how exposure to IFNγ would affect transcription. By expos-
ing cells to a constant, saturating concentration of IFNγ, we can assess how the
rate of transcription changes with time.
ktranscription(t) =
d[mRNA]
dt
+ [mRNA] · kdecay. (3.9)
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(b) The transcription rate yields
the adaptation timescale. The
transcription kinetics were converted
into the transcription rate using Equa-
tion 3.9. This curve was fit with an ex-
ponential approach and the adaptation
timescale was computed from the fit.
Figure 3.3: Accounting for a transcriptional lag (adaptation time) after initiation
of the signaling response.
(Figure 3.3a) shows how the rate of transcription changes following IFNγ ex-
posure. We observed an adaptation period where transcription increases before
reaching a new elevated constant rate (Figure 3.3b). These dynamics can be ap-
proximated by an exponential approach with timescale τadaptation =
1
βadaptation
≈ 12h.
Moreover, the new, elevated, steady state is pSTAT1 dependent, with higher levels
of pSTAT1 translating to an increased transcription rate. In our model, we assume
pSTAT1 linearly increases the maximal transcription rate:
ktranscription → kbasaltranscription + αp (1− exp (−βadaptationt)) pSTAT1,
where the constant αp represents the proportionality between increase in transcrip-
tion and pSTAT1. The updated transcription equation (3.4) is now:
d[mRNA]
dt
= kbasaltranscription + αp (1− exp (−βadaptation · t)) pSTAT1− [mRNA] · kdecay.
(3.10)
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We will next present solutions for this equation under different conditions.
3.3 Exposure to constant IFNγ.
When cells are exposed to a constant concentration of IFNγ, the solution to equa-
tion 3.10 is approximately a bounded exponential growth with an asymptote at
[mRNA]([IFNγ])asympt =
ktranscription+αp·pSTAT1([IFNγ])
kdecay
.
[mRNA](t, [IFNγ]) =
kbasaltranscription + αp · pSTAT1([IFNγ])
kdecay
− αp · pSTAT1([IFNγ])
kdecay − βadaptation exp (−βadaptationt)
+
αp · pSTAT1([IFNγ])βadaptation
kdecay (kdecay − βadaptation) exp (−kdecayt)
(3.11)
3.4 Exposure to transient IFNγ.
Next, we solve the equation assuming transient exposure to IFNγ (0 < t < t0).
Initially, as for the constant case, there is an exponential approach to an elevated
state. Once IFNγ is removed, mRNA levels exponentially decrease back to their
original level of
kbasaltranscription
kdecay
(Figure 3.4).
16
[mRNA](t, t0, [IFNγ]) =

kbasaltranscription+αp·pSTAT1([IFNγ])
kdecay
− αp·pSTAT1([IFNγ])
kdecay−βadaptation e
−βadaptationt...
+
αp·pSTAT1([IFNγ])βadaptation
kdecay(kdecay−βadaptation)
e−kdecayt for 0 < t < t0
kbasaltranscription
kdecay
+
(
αp·pSTAT1([IFNγ])
kdecay
− αp·pSTAT1([IFNγ])
kdecay−βadaptation e
−βadaptationt0 ...
+
αp·pSTAT1([IFNγ])βadaptation
kdecay(kdecay−βadaptation)
e−kdecayt0
)
e−kdecay(t−t0) for t0 < t
(3.12)
A key feature of these dynamics is that under these considerations the time of
maximal mRNA level, tmax, is equal to the time of signal termination (tmax = t0),
regardless of any parameter choice.
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Figure 3.4: Exposure to transient IFNγ given the simplest model of gene
expression. pSTAT1 is expected to change instantaneously in response to IFNγ.
The transcriptional response is expected to follow an exponential approach with
a transcriptional adaptation time following application of IFNγ, and to degrade
exponentially back to the steady state level after removal of the cytokine.
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3.5 Model parameters
Our mathematical modeling relies on rigorous parameterization. All of the param-
eters in our model are either published, or have been experimentally checked by
us. Some of the parameters below are used exclusively for the updated version of
the mathematical model introduced later in the dissertation.
Table 3.1: Parameters used to model the dynamics of our system.
Parameter Value Unit Source
EC50 2.7±1 pM Figure 7.25a
kXcatch 1.2± 0.1 · 105 M−1s−1 Inferred from Figure 7.24 and 7.27
kXrelease 3.7± 0.4 · 10−5 s−1 Figure 7.27
kremoval 24 h
−1 Our experiments (data not shown)
kmRNAdecay 2.9 · 10−2 h−1 [75]
kproteindecay 2.3 · 10−1 h−1 [75]
ktranslation 0.1 mRNA
−1·s−1 [75]
βadaptation 8± 3 · 10−2 h−1 Figure 3.3a Figure 3.3b
kRon 7.3 · 106 M−1s−1 [71]
kRoff 5 · 10−3 s−1 [71]
IFNγR 2 · 103 molecules·cell−1 [13]
X 4700± 800 molecules·cell−1 Fit in this study
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CHAPTER 4
DETERMINING THE TIMING AFTER IFNγ EXPOSURE WHEN
MELANOMA CELLS BEST ACTIVATE T CELLS.
We sought to quantify the timescale of a cells response to transient IFNγ.
Exposure of cells to IFNγ is known to increase their recognition and killing by
T cells [73]. We quantitatively tested this observation by creating an assay that
functionally reports when IFNγ-pulsed cells are most sensitive to T cell recogni-
tion. B16 mouse melanoma cells were pulsed briefly (5h) with IFNγ, then washed
and cultured in cytokine-free conditions (Figure 4.1a). Subsequent to IFNγ expo-
sure, pmel T cells were added to the culture and their activation was quantified
by measuring cytokine secretion. Pmel CD8+ T cells specifically recognize the
endogenously-expressed gp100 peptide antigen presented by MHC-I on melanoma
cells (Figure 4.1b) [60].
time(day) 
time post-IFNγ wash 
time of IFNγ exposure (5h)  
n… -3 -2 -1 0 
… 
+pmel T cells 
quantify pmel activation 
B16 cells 
(a) Diagram of experimental setup.
Different flasks of B16 cells were pulsed
daily for 5h with 10nM IFNγ, then
washed thoroughly. After 7 days, day
5 pmel blasts were co-cultured with an
equal number of B16 cells for 7 hours,
and pmel activation was quantified by
Miltenyi IFNγ cytokine secretion as-
says.
B16 melanoma 
cell 
pmel 
T cell 
Peptide-
presenting 
MHC-I 
T cell 
receptor IFNγ 
Activation 
(b) Cartoon of the experimental
system. B16 mouse melanoma cells
present the endogenous melanoma dif-
ferentiation antigen gp100 by MHC-I
(H2-Db). Pmel CD8+ T cells have a
transgenic TCR specific for gp100 pre-
sented in the context of MHC-I.
Figure 4.1: Diagrams outlining the B16 mouse melanoma-Pmel system and exper-
imental setup
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IFNγ-pulsed melanoma cells increased over time in their capacity to activate T
cells, peaking around two days post-exposure (Figure 4.2). By 5-7 days the capacity
of B16 cells to activate T cells returned to pre-treatment levels. The observation
that T cell activation peaked at two days implied that B16 cells persistently up-
regulated cytokine-response genes for days after removal of the original signal.
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Figure 4.2: B16 cells best activate T cells 2 days after their initial expo-
sure to IFNγ Pmel production of IFNγ was used as a readout of activation and
quantified by flow cytometry. Data plotted is the mean and s.e.m. (errorbars) and
representative of 3 independent experiments.
It is worth noting that the actual magnitude of T cell activation in these ex-
periments is small. After seven hours of co-culture, only about 3− 5% of the total
T cells in the culture become activated (IFNγ+). If the T cells are naive at the
time of co-culture, activation does not occur for any cells over the 7 hour period for
any marker of activation, including Interleukin 2 receptorα up-regulation, CD69
up-regulation, or phosphorylation of Erk protein (data not shown). Why is the
activation in our system so weak? Many immunological assays make use of trans-
genic T cell receptors and engineered antigens. An example of one such system is
the OT-1 - ovalbumin (OVA) system where the T cell receptor specifically recog-
nizes an OVA-derived peptide when presented in the context of MHC-I. OVA is a
non-self derived peptide and is therefore often introduced into antigen presenting
cells by exposing the cells to a large dose of exogenous OVA. In these experiments
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it is not unusual to observe a large fraction of activated T cells in the cultures due
to both the strength of the T cell receptor - peptide MHC interaction, and also to
the abundance of OVA after antigen presenting cells are pulsed with it. Gp100 is
a natural, endogenous peptide and is therefore presented at much lower frequency
than if cells were pulsed with a high concentration of free peptide. In addition,
gp100 is a self-derived peptide - a melanocyte differentiation antigen, thus the
strength of T cell receptor interaction is much weaker. Taken together, we actu-
ally view the weak activation observed in our assays as a strength of our system,
because it more faithfully recapitulates what is likely to occur in vivo during an
actual T cell response to melanoma.
We hypothesized that genes in the antigen presentation cluster caused the pat-
tern of T cell activation that we observed. To test this, we repeated our T cell acti-
vation assay with several additional conditions (Figure 4.3a). To a second group of
melanoma cells, we blocked MHC-I-T cell receptor interaction with a neutralizing
antibody. Additionally, EL4 mouse thymoma cells, which possess the appropriate
MHC-I haplotype but lack the specific peptide antigen were pulsed with IFNγ and
cultured with T cells. After exposure to IFNγ, EL4 cells up-regulated MHC-I ap-
proximately 3-fold, indicating that they do respond to the cytokine (not shown).
T cell activation was completely abrogated when MHC-I was blocked, or in the
absence of peptide antigen in the case of EL4 cells (Figure 4.3b). Together, these
data show that the long-term pattern of T cell activation after brief exposure to
IFNγ is peptide-specific, and dependent on the MHC class I antigen presentation
pathway.
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time(day) 
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time of IFNγ exposure (5h)  
n… -3 -2 -1 0 
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+pmel T cells -/+αMHC-I 
quantify pmel activation 
B16 or 
EL4 cells 
(a) Diagram of experimental setup.
Different flasks of B16 or EL4 cells were
pulsed daily for 5h with 10nM IFNγ,
then washed thoroughly. After 7 days,
day 5 pmel blasts were co-cultured with
an equal number of B16 or EL4 cells,
and pmel activation was quantified by
cytokine secretion assays. An additional
cohort of B16-pmel co-cultures received
neutralizing antibodies directed against
MHC-I, disrupting TCR-MHC-I inter-
actions.
0 2 4 60
20
40
60
80
100
Time post−IFNγ (day)
Ac
tiv
at
io
n 
(%
 of
 m
ax
)
T cell activation
 
 
B16
EL4
B16+αMHC−I
(b) The pattern of T cell activation
is MHC-I and peptide-dependent
Pmel production of IFNγ was used as
a readout of activation and quantified
by flow cytometry. Data plotted is the
mean and s.e.m. (errorbars) and repre-
sentative of 2 independent experiments.
Figure 4.3: The delayed pattern of T cell activation is MHC-I and peptide-
dependent
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CHAPTER 5
QUANTIFYING THE TEMPORAL DURATION OF THE CELL
GENE EXPRESSION RESPONSE TO TRANSIENT IFNγ.
We reasoned that the time points when melanoma cells best-activated T cells
would coincide with their peak expression of IFNγ-response genes. To check
whether the dynamics of IFNγ-response genes matched those of T cell activa-
tion, we quantified mRNA from melanoma cells using RNA-sequencing for several
days after IFNγ exposure. We used RNA-seq to gain a genome-wide view of the
melanoma response to transient IFNγ.
To perform this experiment, B16 melanoma cells were either mock-treated or
pulsed with 10nM IFNγ for 5h, then thoroughly washed. RNA was then harvested
and purified at the indicated timepoints. The Integrated Genomics Organization
at Memorial Sloan Kettering Cancer Center (MSKCC) performed quality checks
on our purified RNA to ensure that it was of sufficient quality to proceed, then
prepared a library of complementary DNA (cDNA), and performed sequencing.
The resulting reads were aligned by the Bioinformatics core facility at MSKCC.
We carried out the remaining bioinformatics analysis using MATLAB software.
Figure 5.1 details the process of filtering genes. In addition, filtering is explained
in further detail in the following paragraph.
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Figure 5.1: Bioinformatic pipeline Each line shows the mean of duplicate RNA
samples and the dataset shown represents the IFNγ dataset as an example. For
each dataset (IFNγ-pulsed and mock-pulsed), genes were first filtered based on
their inclusion in all timepoints. Next, genes were filtered based on variance and
then based on fold change. Finally, all genes which remained in the mock-treated
condition and also in the IFNγ condition were removed from the IFNγ dataset.
At first, each dataset (mock-treated or IFNγ-pulsed) contained about 13,500
genes. For both datasets, we removed genes which did not have all timepoints.
This eliminated about 5% of the total genes. Genes were then masked based
on variance using the MATLAB function genevarfilter. This function ranks the
variance between transcript expression at each timepoint and eliminates genes
which fall into the bottom 20%, essentially removing all genes which stay relatively
static over time. Next, the remaining genes were filtered based on their degree of
up- or down-regulation. Any genes which were not up- or down-regulated by
at least 4 fold were removed, leaving us with about 7% of the remaining genes.
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Finally, all genes which remained in the IFNγ-pulsed dataset that were also present
in the mock-treated control group were eliminated. This analysis left us with 271
genes which changed specifically, and significantly in response to transient IFNγ
treatment.
Our next goal was to identify the major classes of transcriptional dynamics in
response to IFNγ. Our assumption was that the unifying feature of each transcrip-
tional class would be the mode of gene regulation. In other words, we predicted
that genes that clustered together would be regulated similarly. Tavazoie et al.
used the k-means algorithm to cluster sequencing data obtained from synchronized
yeast cultures to identify classes of transcriptional dynamics [84]. They predicted
that each class would be regulated similarly and identified common cis-regulatory
motifs in genes belonging to the same cluster. This strongly suggested that tran-
scription factor bias for a particular motif regulated the dynamics of transcript
expression.
Our 271 transcriptional dynamics were grouped based on their similarity to one
another using the MATLAB k-means algorithm. The initial cluster centroid was
chosen randomly, and the distance metric which was minimized was the euclidean
distance between the sample points and the cluster centroid (Figure 5.2). The
algorithm was iterated until the distance metric was minimized. To determine
the appropriate number of clusters, we used the elbow method (Figure 5.3). In
other words, the algorithm was run for increasing number of clusters and the
number of clusters was plotted versus the distance. The point at which this curve
forms an ”elbow” is the point at which the distance between the data and the
model no longer appreciably falls with each added cluster. After the elbow, newly
added centroids cluster transcriptional trajectories based on small differences or
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experimental noise and fail to convey new features of the dynamics.
0 1 2 3 4−5
0
5
10
15
Cluster 1
n=121
Lo
g2
 fo
ld 
ch
an
ge
0 1 2 3 4
Cluster 2
n=28
Time post−IFNγ (day)
0 1 2 3 4
Cluster 3
n=122
genes
cluster centroid
Figure 5.2: Clustering of transcript dynamics reveals 3 classes of tran-
scription. Genes were clustered using the k-means algorithm. Each line represents
the mean of duplicate RNA samples.
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Figure 5.3: The elbow method for determining number of clusters. The
k-means algorithm was run for increasing number of clusters (n=1-50).
We chose the two candidate genes from cluster 1, H2-Db and H2-Kb, which en-
code both haplotypes of mouse MHC-I, to confirm that protein expression matched
that of mRNA expression (Figure 5.4). B16 cells were pulsed with 10nM IFNγ,
washed, and cultured in fresh media. To quantify protein, cells were harvested at
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the indicated timepoints, stained for both MHC-I haplotypes (H2-Kb and H2-Db),
and fluorescence was quantified by flow cytometry.
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Figure 5.4: The dynamics of MHC-I protein expression match those of
mRNA. Expression of both MHC-I haplotypes was quantified by flow cytometry
and plotted along with the time dynamics of each proteins’ corresponding tran-
script from sequencing data. For both protein and mRNA, data is representative
of at least 3 independent experiments.
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CHAPTER 6
CHARACTERIZING THE GENE EXPRESSION SIGNATURE OF
MELANOMA CELLS FOLLOWING TRANSIENT EXPOSURE TO
IFNγ.
Clustering of the mRNA dynamics enabled identification of three main tran-
scriptional classes. Gene ontology analysis [5, 25] was performed on each cluster to
identify significantly enriched biological pathways (Figure 6.1). Cluster 1 was sig-
nificantly enriched with genes involved in the MHC-I and II antigen presentation
pathways, which are critical for T cell activation. Furthermore, these genes exhib-
ited a pattern of expression very similar to that of T cell activation. From here on,
we will refer to this cluster as the antigen presentation cluster. In Cluster 2, there
were no significantly enriched biological pathways. Cluster three was modestly
enriched with genes involved in cell cycling, however, since cell cycle genes are not
typically associated with T cell activation, we focused on cluster 1. Specifically,
we asked what molecular mechanism extends the cells’ transcriptional response in
the absence of the original signal.
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Figure 6.1: GO analysis reveals enrichment for the class I and II antigen
presentation pathway. Gene ontology analysis was performed for genes in each
cluster. Every pathway that was significantly enriched with a p-value < 0.05 was
kept and plotted.
6.1 Summary
To summarize data from the previous sections, our in vitro assay established that
B16 melanoma cells respond to transient IFNγ (5h) with sustained up-regulation
of genes in the antigen presentation pathway that peak in expression 2 days post-
exposure. Thus, the cell response to IFNγ extends long past the time when the
original cytokine is gone. This persistent up-regulation of antigen presentation
genes is functionally important, because it controlled T cell activation. The re-
mainder of the dissertation will be devoted to uncovering the molecular mechanism
responsible for persistent transcription of IFNγ-response genes.
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CHAPTER 7
IDENTIFYING THE MOLECULAR MECHANISM(S) THAT
REGULATE THE TEMPORAL DURATION OF THE MELANOMA
RESPONSE TO TRANSIENT IFNγ.
7.1 JAK-STAT signaling drives persistent transcription
We asked what mechanism drives the long-term pattern of gene expression we
observed in response to transient IFNγ. Downstream of the IFNγ receptor, the
transcription factor STAT1 is phosphorylated (pSTAT1) and drives gene expres-
sion changes. If STAT1 is persistently phosphorylated after IFNγ withdrawal, it
could drive persistent up-regulation of antigen presentation genes. We tested this
experimentally by exposing cells to IFNγ for several hours, followed by thorough
washing (Figure 7.1a). Cells were harvested periodically for intracellular phospho-
flow cytometry of pSTAT1. After stimulation with IFNγ, pSTAT1 peaks rapidly,
and decays to about 10% of the maximum after washing (Figure 7.1b). Phospho-
rylated STAT1 then increases to 20% of its maximum one day later, before slowly
decaying back to baseline four days after the initial exposure.
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(a) Diagram of pSTAT1 experi-
ment setup. B16 cells were pulsed for
5h with 10nM IFNγ, then washed. At
indicated timepoints cells were rapidly
fixed, permeabilized, then stained.
pSTAT1 was quantified by flow cytom-
etry.
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Figure 7.1: Phosphorylation of STAT1 persists long after removal of IFNγ.
Persistent phosphorylation of STAT1 requires JAK activity, because applica-
tion of a JAK inhibitor after IFNγ-stimulation caused rapid decay of pSTAT1
signaling (Figure 3.2b). We checked whether JAK-STAT signaling is necessary for
persistent transcription of antigen presentation genes by applying a JAK inhibitor
to cells and quantifying h2kb transcript over time (Figure 7.2a). Cells that were
JAK inhibited after IFNγ-stimulation peaked at five hours, which was the time
when JAK inhibitor was applied to cells (Figure 7.2b). Taken together, these data
show that after washing, pSTAT1 does not rapidly return to its baseline level,
instead, STAT1 is persistently phosphorylated for several days. In addition, this
persistent JAK-STAT signaling is necessary for continued transcription of antigen
presentation genes.
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Collect RNA for qPCR 
(a) Diagram of JAKi experiment.
B16 cells were pulsed for 5h with 10nM
IFNγ, then washed. Alternatively,
washed cells were exposed to 10µM of
the JAK inhibitor AZD1480. At in-
dicated timepoints cells RNA was har-
vested and h2kb transcript was quanti-
fied by RT-qPCR.
0 1 2 3 4 50
20
40
60
80
100
Time post−IFNγ (day)
N
or
m
al
iz
ed
 h
2k
b 
(%
 of
 m
ax
)
mRNA
 
 
+JAKi
Wash
(b) Persistent MHC-I transcription
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dent experiments.
Figure 7.2: Persistent transcription of h2kb is JAK-STAT-dependent
Persistent JAK-STAT signaling could be explained by positive feedback induced
through α, β, or γ interferon. IFNα/β are induced in response to stimulation with
IFNγ, albeit at low levels, and also signal through STAT1 [1, 73]. However, nei-
ther α nor β interferons drove persistent up-regulation of the antigen presentation
pathway (Figure 7.3).
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Figure 7.3: Type I Interferons do not drive persistent up-regulation of
antigen presentation genes. Cells were stimulated with 10nM IFNγ, then
washed. At the time of wash, one cohort of cells received neutralizing antibodies
directed against both the common receptor for IFNα/β and the cytokine IFNβ.
The other cohort received IgG control antibodies. MHC-I was measured by flow
cytometry. Data plotted is the mean and s.e.m. (errorbars) and representative of
3 independent experiments.
To test whether IFNγ drives persistent gene up-regulation, we stimulated cells
with cytokine for several hours, washed, and added a neutralizing antibody directed
against soluble IFNγ (Figure 7.4a). Indeed, extracellular blocking of IFNγ after
the initial washout caused an early peak in the MHC-I protein H2-Kb relative to
the control (Figure 7.4b).
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(a) Diagram of αIFNγ experiment.
B16 cells were pulsed with 10nM IFNγ,
then washed. At the time of wash one
cohort of cells received neutralizing an-
tibodies directed against IFNγ. MHC-I
was measured by flow cytometry.
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Figure 7.4: Persistent up-regulation of antigen presentation genes is IFNγ-
dependent
We estimated that the washing we perform after IFNγ exposure amounts to an
approximate billion-fold dilution of the original IFNγ concentration. Specifically,
after a 5h culture with IFNγ, cells are centrifuged, then washed three consecutive
times with a large volume (10mL) of warm culture media. However, we confirmed
that conditioned media harvested immediately after the last wash does not cause
up-regulation of antigen presentation genes when cultured with naive B16 cells
(Figure 7.5). To confirm this, B16 cells were pulsed for 5h with 10nM IFNγ, then
washed. Immediately after the last wash, the conditioned media was harvested
from the B16 cells. Next, a fresh, unstimulated cohort of cells were stimulated
with either media alone, 10nM IFNγ, or conditioned media. MHC-I was measured
by flow cytometry after 1 day of culture. Since IFNγ-pulsed cells were only exposed
to the conditioned media for an approximate 3 minute wash, any up-regulation of
MHC-I in response to the conditioned media could be attributed to residual IFNγ
remaining in the media caused by insufficient washing.
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Figure 7.5: Persistent transcription of antigen presentation genes is not
caused by insufficient washout of IFNγ. B16 cells were pulsed for 5h with
10nM IFNγ, then washed. Immediately after the last wash, conditioned media
was harvested. A fresh cohort of cells were cultured in either conditioned media,
10nM IFNγ, or media alone for 1 day. MHC-I was quantified by flow cytometry.
Given that an IFNγ antibody blockade prevents sustained up-regulation of
IFNγ response genes, we hypothesized that IFNγ induces its own production via a
positive feedback loop. However, when we checked our sequencing data, we did not
observe induction of the ifng gene, suggesting the cytokine originates from cells in
a manner independent of transcription. In summary, IFNγ drives persistent JAK-
STAT signaling, which causes persistent up-regulation of the antigen presentation
pathway. However, cells do not transcribe IFNγ.
7.2 IFNγ-exposed cells release cytokine with very slow ki-
netics
We next asked whether IFNγ originates from cytokine-pulsed cells. To test this,
we set up a transwell assay (Figure 7.6a). In this assay, one group of cells were
stimulated with IFNγ, washed, and co-cultured in the bottom of a plate with
naive, un-stimulated sensor cells. We distinguished between the two groups by
labeling sensor cells with a fluorescent dye. An additional group of un-stimulated
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sensor cells were spatially separated from cytokine-pulsed sharing cells by placing
them in the top of a 0.4µm pore diameter transwell insert. This pore size allows
molecules, but not cells to freely pass across. MHC-I on sensor cells was measured
by flow cytometry after one day of co-culture. We reasoned that if IFNγ originates
from pulsed cells, only sensor cells cultured in the bottom of the plate (in close
proximity) with pulsed cells would up-regulate MHC-I at this timepoint. To ensure
that any effects we observed were dependent on IFNγ, an additional well received
IFNγ neutralizing antibodies.
Our results validated our hypothesis that IFNγ originates from cytokine-pulsed
cells. Sensor cells cultured in close proximity with IFNγ-pulsed cells up-regulated
MHC-I approximately 10-fold after 1 day of co-culture (Figure 7.6b). However,
sensor cells cultured in the top of the transwell or in close proximity with IFNγ-
pulsed cells, but with IFNγ neutralizing antibodies did not up-regulate MHC-I.
(a) Cartoon diagram of transwell
experiment. One group of cells were
pulsed with 10nM IFNγ for 5h, then
washed. Cytokine-pulsed cells were co-
cultured in the bottom of of a tran-
swell with fluorescent-labeled, naive, un-
pulsed sensor cells. An additional group
of sensor cells were cultured on the top
of a transwell insert that is permeable to
small molecules, but not cells. As a con-
trol, an additional well received neutral-
izing antibodies directed against IFNγ.
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(b) IFNγ originates from cytokine-
pulsed cells. MHC-I was measured by
flow cytometry after 1 day of co-culture.
Experiment is representative of at least
3 independent experiments.
Figure 7.6: IFNγ originates from cytokine-pulsed cells.
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To determine whether cell-to-cell cytokine sharing is dependent on cell prox-
imity or cell contact, we measured MHC-I expression on sensor cells in the top
and bottom of the transwell after multiple days of co-culture. After several days,
sensor cells mixed in the bottom of the transwell continued to up-regulate MHC-I,
and sensor cells in the top of transwell began to up-regulate MHC-I, eventually
reaching levels comparable to mixed sensor cells (Figure 7.7). This suggested that
IFNγ is slowly released from IFNγ-pulsed sharing cells and diffuses up to sensor
cells in the top of the transwell over time. Thus, cell-to-cell cytokine sharing likely
depends on proximity (due to diffusion), but not cell contact.
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Figure 7.7: Cell-to-cell cytokine sharing is proximity, but not contact-
dependent. The transwell assay was repeated and timepoints were taken for
several days. MHC-I was measured by flow cytometry.
We then asked whether other cell types exhibit cell-to-cell cytokine sharing. A
panel of mouse and human cells were pulsed with mouse IFNγ, then washed and
co-cultured with naive, unstimulated B16 sensor cells (Figure 7.8a). Specifically,
B16 mouse melanoma, Mel-2 human melanoma, H460 human lung carcinoma,
CH12 mouse B cell lymphoma, Hek293T human embryonic kidney, and RAW
mouse macrophages were all pulsed with 10nM mouse IFNγ for 5h, washed, and
co-cultured with naive, unstimulated B16 sensor cells. MHC-I was measured on
B16 sensor cells as a readout of cell-to-cell cytokine sharing. The strength of
37
this experiment is that cell-to-cell cytokine sharing can be compared across cell
lines because only one cell type (B16) reads out the response. If we had used
different sensor cells, variable responsiveness to IFNγ could confound comparison
between groups. All cell types assayed, including tumor- and non-tumor derived,
were capable of sharing IFNγ with B16 cells (Figure 7.8b). These experiments
demonstrated that IFNγ can be captured by diverse cell types and then slowly
released over long timescales to signal in a manner dependent on cell proximity,
but not contact. In addition, these results indicated that the mechanism of IFNγ
capture by cells is not species-specific.
(a) Cartoon diagram of sen-
sor/sharer experiment. This
experimental design applies generally
to several of the following experiments.
One group of cells were first pulsed
with 10nM IFNγ, then washed and
co-cultured with another group of
fluorescently-labeled, naive, unstimu-
lated sensor cells. MHC-I on sensor
cells was measured by flow cytometry
after 1 day of co-culture.As a control,
an additional well received neutralizing
antibodies directed against IFNγ.
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(b) IFNγ can be shared by di-
verse cell types. A panel of diverse,
tumor- and non-tumor-derived human
and mouse cell lines were pulsed for 5h
with 10nM mouse IFNγ, then washed
and co-cultured with naive, unstimu-
lated B16 sensor cells. MHC-I was mea-
sured by flow cytometry after 1 day of
co-culture. Data plotted are mean and
s.e.m. (errorbars).
Figure 7.8: Cell-to-cell cytokine sharing is observed in diverse cell types.
We also checked whether human IFNγ can participate in cell-to-cell cytokine
sharing. Human H460 lung carcinoma cells and Mel-2 human melanoma cells were
pulsed with 10nM human IFNγ for 5h, then washed and co-cultured with naive, un-
stimulated H460 or Mel-2 as sensor cells. Expression of Human Leukocyte Antigen
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A/B (HLA-A/B) was quantified by flow cytometry after 24h of co-culture. Indeed,
human IFNγ can also participate in cell-to-cell cytokine sharing (Figure 7.9). No-
tably, the degree of HLA up-regulation was much lower in these human cell lines
when compared to B16. This illustrates the degree of cell type-to-cell type vari-
ability in responsiveness to IFNγ.
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Figure 7.9: Human IFNγ also participates in cell-to-cell cytokine sharing.
H460 or Mel-2 human cells were pulsed with 10nM human IFNγ, washed, and co-
cultured with naive, unstimulated cells as sensors. Expression of HLA-A/B was
quantified by flow cytometry as a readout of cell-to-cell cytokine sharing. The
data plotted are mean and s.e.m (errorbars) and representative of 2 independent
experiments. Statistical significance was computed using an unpaired T test.
We next addressed whether IFNγ de-binds from IFNγ receptors after washing
to mediate signaling. Based on our previous results, this would imply that mouse
IFNγ can at least bind to both the human and mouse IFNγ receptor. To test
this, we repeated our assay with B16 IFNγ receptor knockout (B16 IFNγR KO)
cells. These cells were pulsed with IFNγ, washed, and co-cultured with receptor
competent B16 sensor cells (Figure 7.8a). We again observed IFNγ-dependent
up-regulation of MHC-I on sensor cells despite lack of the IFNγ receptor on IFNγ-
pulsed cells (Figure 7.10a). This showed that IFNγ associates with cells in a
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receptor-independent manner.
Finally, we repeated this assay with a stringent wash. We pulsed B16 IFNγR
KO cells with IFNγ for 5h, then washed them. Cells were then briefly exposed to
a low-pH solution at 4◦C. This acid-stripping has been shown to remove all non-
covalently bound molecules from cell surfaces [17]. Acid-stripped cells were then
co-cultured with B16 sensor cells. We found that acid-stripping knocked down the
ability of IFNγ-exposed sharer cells to induce MHC-I up-regulation, but did not
completely eliminate it (Figure 7.10b). MHC-I up-regulation on sensor cells was
reduced by approximately 5-fold when sensors were co-cultured with acid-stripped
cells. This suggests that some of the shared IFNγ is present on the cell surface
while an additional fraction remains inside the cells.
40
05
10
Se
ns
or
 H
2−
Kb
 
(a.
u.)
IFNγR KO sharers
 
 
Alone
+IFNγ pulsed sharer
+IFNγ pulsed sharer+αIFNγ
(a) Cell-to-cell cytokine sharing is
mediated by IFNγ de-binding from
the IFNγR. B16 IFNγR KO cells were
stimulated with 10nM IFNγ for 5h,
then washed and co-cultured with naive,
unstimulated, receptor-competent B16
sensor cells. MHC-I on sensor cells
was measured by flow cytometry after
1 day of co-culture. As a control, an
additional well received neutralizing an-
tibodies directed against IFNγ. Data
plotted is mean and s.e.m. (errorbars)
and representative of at least 3 indepen-
dent experiments.
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(b) Some IFNγ is internal and some
is surface-exposed. B16 IFNγR KO
cells were pulsed with 10nM IFNγ for
5h, then washed. After washing, one co-
hort of cells was washed with stripping
buffer (0.25M glycine, 0.125M NaCl,
pH 4.0) [17]. This acid-strip wash re-
moves everything that is non-covalently
bound to the cell surface. Cells were
then cultured with naive, unstimulated,
receptor-competent B16 sensor cells.
MHC-I on sensor cells was measured by
flow cytometry after 1 day of co-culture.
Data plotted is mean and s.e.m. (error-
bars) and representative of 2 indepen-
dent experiments.
Figure 7.10: IFNγ is both intracellular and surface-exposed, and its release is
independent of the IFNγR
IFNγ produced by activated primary T cells is known to undergo post-translational
modifications [22], so we wanted to verify that both T cell-derived and recombi-
nant IFNγ associate with cells. To this end, we developed a quantitative IFNγ
cell capture assay (Figure 7.11). B16 IFNγR KO cells were pulsed with 50pM T
cell-derived or recombinant IFNγ in a well-mixed setting for several hours. The
culture media was then harvested from cells and a bead-based ELISA was used
to quantify the depletion of IFNγ from the media. We confirmed that both T
cell-derived and recombinant IFNγ could be captured equivalently by IFNγR KO
cells (Figure 7.12).
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Figure 7.11: Cartoon diagram of cytokine capture assay. B16 IFNγR KO
cells were pulsed with 50pM cytokine in 50µL total volume in a well-mixed set-
ting for several hours. The culture media was then harvested from cells and a
bead-based ELISA was used to quantify the depletion of IFNγ from the media.
A standard curve was used to convert bead fluorescence into cytokine molarity.
Molarity was then converted into number of molecules per tube. The amount of
cell-based capture was quantified by taking the difference between the number of
molecules in the cell free condition and the number of molecules in the conditions
with added cells.
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Figure 7.12: Recombinant and T cell-derived IFNγ associate with cells
equally well. B16 IFNγR KO cells were pulsed with 50pM T cell-derived or
recombinant IFNγ in a well-mixed setting for several hours. The culture media
was then harvested from cells and a bead-based ELISA was used to quantify the
depletion of IFNγ from the media.
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To summarize this section, IFNγ can be captured by cells, exists primarily on
the membrane or is at least accessible to acid-based removal, and is released slowly
to signal to neighboring cells in a proximity-dependent manner.
7.3 IFNγ cell capture is cholesterol-dependent
We then sought to identify what surface molecule would achieve this slow catch-
and-release. IFNγ has been shown to associate electrostatically with peri-cellular
matrix proteoglycans such as chondroitin sulfate and heparan sulfate [7, 51]. These
peri-cellular proteoglycans are fairly ubiquitous across cell lines that form epithelia
and grow in monolayers (our own data, not shown). We repeated our IFNγ cell
capture assay (Figure 7.11) after enzymatic removal of heparan sulfate and chon-
droitin sulfate, however, we observed no reduction in IFNγ cell association (Fig-
ure 7.13). In addition, treatment of cells with dynasore, an inhibitor of clathrin and
dynamin-dependent endocytosis, did not inhibit IFNγ cell capture (Figure 7.13).
We next tested whether IFNγ associated with a protein on the cell surface by
digesting cell-surface proteins with pronase [83], then performing the IFNγ cell
capture assay. Again, there was no reduction in IFNγ cell association despite pro-
tein digestion (Figure 7.13). Surprisingly, IFNγR-independent capture of IFNγ
on the cell surface did not depend on proteins, clathrin-dependent endocytosis, or
proteoglycans.
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Figure 7.13: IFNγR-independent capture of IFNγ on the cell surface does
not depend on proteins, internalization, or proteoglycans. B16 IFNγR
KO cells were pulsed with 50pM T cell-derived or recombinant IFNγ in a well-
mixed setting for two hours. The culture media was then harvested from cells
and a bead-based ELISA was used to quantify the depletion of IFNγ from the
media. For ganglioside depletion, cells were treated with 10µM of either Fumonisin
B1 or PDMP (N-[2-hydroxy-1-(4-morpholinylmethyl)-2-phenylethyl]-decanamide,
monohydrochloride), or DMSO as a vehicle control for 3 days prior to performing
the capture assay [70]. To block clathrin and dynamin-dependent endocytosis, cells
were treated with 30µM dynasore for 1h prior to performing the capture assay. To
digest cell surface proteoglycans, cells were treated with 5U/mL either heparinase I,
III, or chondroitin ABC lyase 1h prior to performing the assay. To digest proteins,
cells were treated with 0.01% pronase for 30 minutes prior to performing the assay
[83].
To get a clue about what cell surface molecule IFNγ could bind to, we gener-
ated fluorescently-tagged IFNγ (IFNγ-A647 and IFNγ-A488). This enabled us to
visualize the spatial distribution of IFNγ when captured by the cell. To ensure
that our fluorescently-tagged IFNγ behaved like recombinant, unlabeled IFNγ, we
performed a panel of control experiments (Figure 7.14).
First, we confirmed that fluorescent IFNγ could be captured by cells on a pop-
ulation wide scale (black). Second, we confirmed that residual dye left in the prep
could not bind cells, potentially resulting in false positive staining (red). Third,
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we confirmed that the binding of IFNγ-A647 to cells is specific by pre-incubating
cells with unlabeled IFNγ before IFNγ-A647 (cyan). This treatment did result in
an increase in cell fluorescence, however, based on simple binding-debinding, we
would assume that after several hours of culture with equimolar concentrations of
unlabeled IFNγ and IFNγ-A647, there would be some replacement of the unlabled
IFNγ. The observation that pre-treatment with unlabeled IFNγ strongly reduces
the cell fluorescence relative to the untreated control indicates that the binding is
specific. Finally, we checked whether IFNγ-A647 could be partially stripped from
cells by treatment with low pH glycine buffer, similar to unlabeled IFNγ in (Fig-
ure 7.10b) (blue). In (Figure 7.10b), acid stripping of cells pulsed with unlabeled
IFNγ resulted in a 5-fold reduction in sensor cell MHC-I expression. Similar to
this result, acid stripping of fluorescently-tagged IFNγ reduced cell fluorescence by
5-fold. This result suggests that some of the IFNγ is protected from acid treatment
possibly due to an intracellular location. Taken together, these controls suggest
that fluorescently-tagged IFNγ behaves similarly to unlabeled IFNγ.
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Figure 7.14: Association of IFNγ-A647 with cells is specific. B16 IFNγR
KO cells were pulsed for 3.5 hours with 10nM IFNγ-A647 while tumbling in RPMI,
then washed (black). To acid strip, cells treated with IFNγ-A647 were first washed
once in cold PBS, then exposed to glycine stripping buffer (0.25M glycine, 0.125M
NaCl, pH 4.0) for 2 minutes on ice. Cells were then rapidly pelleted, washed once
in cold FACS buffer, and kept on ice. To pre-treat cells with unlabeled IFNγ,
cells were pre-treated with 10nM IFNγ for 3.5 hours after which 10nM IFNγ-A647
was spiked in for an additional 3.5 hours. To assess the potential non-specific
binding or uptake of dye particles left in the prep, we prepared a protein-free
sample of Alexa647 carboxylic acid succinimidyl ester dye treated exactly as the
IFNγ-A647 was treated and exposed an equal quantity to cells for 3.5 hours. Data
are representative of 2 independent experiments.
In addition, we confirmed that fluorescent IFNγ is functionally equivalent to
unlabeled, recombinant IFNγ (Figure 7.15). B16 IFNγR KO cells were pulsed
with 10nM either fluorescent or unlabeled IFNγ for 5h then washed. Washed cells
were co-cultured with unstimulated sensor cells for 24 hours. αIFNγ was added to
relevant wells to block IFNγ signaling.
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Figure 7.15: Fluorescent IFNγ is functionally equivalent to unlabeled
IFNγ. B16 IFNγR KO cells were pulsed with 10nM either fluorescent or unlabeled
IFNγ for 5h then washed. Washed cells were co-cultured with unstimulated sensor
cells for 24 hours. αIFNγ was added to relevant wells to block IFNγ signaling.
MHC-I was measured after 1 day of co-culture. Data plotted are mean and s.e.m.
(errorbars).
Cells were then imaged using confocal microscopy. B16 IFNγR KO cells were
adhered to the surface of fibronectin-coated glass-bottom culture plates, then
pulsed for several hours with 10nM IFNγ-A4647. Cells were washed with phenol-
free RPMI and imaged. Imaging revealed that IFNγ assumed a punctate pattern on
cells, and this morphology resembled membrane lipid micro-domains (Figure 7.16)
[24].
10 µm IFNγ
Figure 7.16: IFNγ assumes a punctate distribution on cells. B16 IFNγR
KO cells were adhered to fibronectin-coated glass bottom dishes and incubated
with 10nM IFNγ-A647 for several hours, then washed and imaged via confocal
microscopy. Imaging is representative of at least 3 independent experiments.
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Earlier, we showed that acid-stripped IFNγ-pulsed cells exhibit reduced cell-
to-cell cytokine sharing (Figure 7.10b). In addition, acid-stripping reduced IFNγ
cell fluorescence by about 5-fold when cells had been pulsed with IFNγ-A647
(Figure 7.14). These results suggested that there are pools of intracellular and
surface-accessible IFNγ. To check this, we analyzed the intracellular versus cell
surface-bound fractions of IFNγ by confocal microscopy. When cells were flattened
and adhered to glass coverslips, it was difficult to resolve whether IFNγ is intra-
cellular or surface-exposed (Figure 7.16). To circumvent this problem, we pulsed
B16 IFNγR KO cells with 10nM IFNγ-A488 for 5 hours, washed them, stained the
cell membrane with the dye Cell Mask Orange, deposited them on untreated glass
slides, and imaged immediately. Using this strategy the cells remained round and
it was easier to see the subcellular localization of the cytokine based on its position
relative to the cell membrane dye.
We pseudo-colored IFNγ green and cell mask orange red. This way, we could
conclude that yellow color represented co-localization between the cytokine and
the plasma membrane. From this imaging, it was clear that much of the IFNγ
was co-localized with the cell membrane, resulting in a yellow color (Figure 7.17a).
Much of the remaining IFNγ appeared to be just adjacent to or underneath the
cell membrane (Figure 7.17b).
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IFNγ
Cell membrane
(a) Imaging the subcellular local-
ization of IFNγ. B16 IFNγR KO
cells were stimulated with 10nM IFNγ-
A488 for 5 hours, then washed. Washed
cells were then stained with Cell Mask
Orange, which labels the plasma mem-
brane, then deposited and imaged im-
mediately on untreated glass slides. Im-
age is representative of 2 independent
experiments.
(b) Close-up shows surface-exposed
IFNγ. This picture shows a close-up of
the boxed image in A. The arrows show
examples of surface-exposed or plasma
membrane-bound IFNγ. (yellow = co-
localized IFNγ and plasma membrane)
Figure 7.17: IFNγ is both intracellular and surface-exposed.
We also sought to interrogate the IFNγ distribution after treatment with low
pH. In parallel, an additional cohort of IFNγ-A488-pulsed cells were exposed to
acidic stripping buffer for 2 minutes on ice, then washed. Cells were rapidly stained
with Cell Mask Orange and deposited onto untreated glass slides for imaging. Im-
ages of acid-stripped and un-treated cells were acquired using identical microscope
settings. Both sets of images were processed by removing the bottom 2% of red
pixels (to reduce background). Visual examination of these images revealed that
IFNγ fluorescence decreases markedly after acid strip treatment (Figure 7.18a).
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When focusing on a single cell, it was clear that the only remaining IFNγ is deep
inside the cell. All membrane-bound IFNγ and IFNγ situated just under the mem-
brane is effectively removed (Figure 7.18b).
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(a) Imaging the subcellular local-
ization of IFNγ after acid strip-
ping. B16 IFNγR KO cells were stim-
ulated with 10nM IFNγ-A488 for 5
hours, then washed. Cells were then
acid stripped by first washing cells in
PBS, then exposing to acidic stripping
buffer for 2 minutes on ice. Cells were
then rapidly stained with Cell Mask Or-
ange, which labels the plasma mem-
brane, then deposited and imaged im-
mediately on untreated glass slides.
(b) Close-up shows surface-exposed
IFNγ after acid stripping. This pic-
ture shows a close-up of the boxed image
in A. The arrows show an example of
surface-exposed or plasma membrane-
bound IFNγ.
Figure 7.18: IFNγ is both intracellular and surface-exposed.
Consistent with our visual analysis of the images, quantitative comparison re-
veals a shift in the fluorescence of the IFNγ green channel following acid-strip
treatment, whereas the cell membrane channel is super-imposable (Figure 7.19).
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Figure 7.19: Shift in population-wide IFNγ fluorescence after acid strip.
Images were processed by removing the bottom 2% of red pixels. Histograms show
the data from Figure 7.17a and Figure 7.17a
We next tested whether IFNγ co-localized with lipid micro-domains, so we
imaged it together with cholesterol, a known component of lipid rafts [24, 80]. We
loaded cells with fluorescent topFluor(TF)-cholesterol using the cholesterol donor
methyl-β cyclodextrin (MβCD) [36]. TF-cholesterol acts as a cholesterol tracer by
partitioning into cholesterol containing cellular compartments. We observed co-
localization of cholesterol and IFNγ with a Pearson coefficient of 0.6 (Figure 7.20).
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Figure 7.20: Fluorescent IFNγ co-localizes with cholesterol in lipid mi-
crodomains. First, TF-cholesterol was introduced into B16 IFNγR KO cells.
TF-MβCD complexes were mixed in PBS with PBS-washed cells for 5 minutes at
37◦C. Cells were then washed in RPMI and adhered to fibronectin-coated glass-
bottom culture plates. IFNγ-A647 was then added to cells for several hours. Cells
were washed and imaged via confocal microscopy. Imaging is representative of at
least 2 independent experiments.
We then asked whether a lipid could be responsible for cell association. The
glycolipid ganglioside GM1 occupies lipid micro-domains and is a growth factor co-
receptor, so we wondered if it could also bind IFNγ [70]. Ganglioside biosynthesis
was inhibited in B16 IFNγR KO cells for one week using two different drugs:
Fumonisin B and PDMP (N-[2-hydroxy-1-(4-morpholinylmethyl)-2-phenylethyl]-
decanamide, monohydrochloride), before performing our IFNγ cell-capture assay
(Figure 7.11). Neither treatment inhibited IFNγ binding (Figure 7.13).This result
prompted us to ask whether cholesterol itself is necessary for IFNγ cell association.
When not in complex with cholesterol, MβCD acutely depletes cellular choles-
terol [36]. A 40% reduction in IFNγ cell binding was observed when cholesterol
was transiently depleted from cells (Figure 7.21). Further confirming this result,
pharmacologic inhibition of cholesterol biosynthesis using lovastatin reduced IFNγ
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binding by nearly 80%. These data show that cholesterol is both co-localized
with IFNγ and necessary for cell capture of the cytokine. In addition, permanent
disruption of cholesterol using saponin or filipin also resulted in reduced IFNγ
capture. Cholesterol-rich patches on the cell membrane provide an essential scaf-
folding domain for assembly of caveolins [57]. The observation that cholesterol
depletion disrupts cell capture of IFNγ argues for a role of caveolae-dependent
internalization of IFNγ, though this has yet to be definitively proven.
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Figure 7.21: Cholesterol is necessary for IFNγ cell association. To tran-
siently deplete cholesterol with MβCD, B16 IFNγR KO cells were treated with
10mM MβCD in PBS supplemented with 25mM HEPES buffer for 45 minutes at
37◦C. Cells were washed, then the IFNγ cell capture assay was performed. To
permanently disrupt cholesterol, cells were treated with 0.1% saponin in RPMI or
50µg/mL filipin in RPMI for 15 minutes prior to performing the IFNγ cell capture
assay. To disrupt cholesterol biosynthesis, cells were treated with 10µM lovastatin
for 3 days prior to performing the assay. Data plotted are the mean and s.e.m
(errorbars) and representative of 3 independent experiments.
To test whether IFNγ directly bound cholesterol, we performed a lipid im-
munoblot using membranes spotted with cholesterol and a variety of different
lipids. Lipid-spotted strips were probed with 50nM IFNγ, and then with IFNγ-
specific antibodies. IFNγ did not bind directly to cholesterol, however it did bind
to several other lipids (Figure 7.22). These data showed that cholesterol is neces-
sary for IFNγ cell association and possibly internalization, but does not directly
bind the cytokine. In addition, they presented several candidate lipids that may
mediate cell capture. Interestingly, all of the phospholipids capable of binding
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blank cardiolipin
sulfatide phosphatidylglycerol
sphingomyelin phosphatidylcholine
cholesterol phosphatidylethanolamine
PtdIns(3,4,5)P3 phosphatidylserine
PtdIns(4,5)P2 phosphatidic acid
PtdIns(4)P diacylglycerol
phosphatidyl
inositol
triglyceride
Figure 7.22: IFNγ does not directly bind cholesterol, but does bind a
variety of anionic phospholipids. Lipid-spotted strips were incubated with
50nM IFNγ, then washed and probed with a primary antibody directed against
IFNγ. A secondary HRP-conjugated antibody directed against the primary isotype
was then added and blots were developed and visualized. The blot is representative
of 3 independently done blots.
IFNγ are anionic, suggesting that the positively charged c-terminal region of IFNγ
could mediate binding.
To conclude, we uncovered a cytokine catch-and-release phenomenon, whereby
cells exposed to IFNγ capture it on their surface in an IFNγR-independent manner,
internalize it, and then release it to neighboring cells. This allows IFNγ to act over
long timescales by persisting in the environment after the original signal is gone.
We term this mechanism ”cytokine catch-and-release communication.”
7.4 An updated mathematical model recapitulates exper-
imental results
We wanted to see if our mechanistic understanding of the system could be re-
capitulated using a mathematical model. In addition, we hypothesized that by
using a mathematical model, we could quantitatively interrogate the biochemical
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Figure 7.23: Cartoon diagram of the mathematical model. Once exogenous
IFNγ is removed from the system, release of IFNγ from both the receptors and
from the cell drive persistent signaling through the IFNγR until it is consumed
below the threshold of signaling. Cells are allowed to proliferate and IFNγ leaves
the system through endocytosis via the IFNγR.
interactions of IFNγ with the cell. A quantitative understanding of the IFNγ-cell
interaction would enable us to eliminate some of the lipid candidates from figure
Figure 7.22. Mass action kinetics were used to model binding of IFNγ to its re-
ceptor and to the cell (Figure 7.23). Once exogenous IFNγ is removed from the
system, release of IFNγ from the cell drives persistent signaling through the IFNγ
receptor until it is consumed to a quantity below the threshold of signaling.
Our updated mathematical model can be summarized using the following sys-
tem of ordinary differential equations. It builds upon our previous model and
incorporates cell proliferation because the timing of our experimental measure-
ments is on the order of days: sufficient time for cells to undergo several rounds of
division.
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
pSTAT1([IFNγ]) ∝ 1
1+
EC50
[IFNγ]
,
d[X−γ]
dt
= kXcatch · [X] · [IFNγ]− kXrelease · [X − γ],
d[IFNγ]
dt
= −kXcatch · [X] · [IFNγ] + kXrelease · [X − γ]− kcycIFNγ,
(7.1)
where X is the IFNγ non-signaling cell capture site, X−γ is the IFNγ captured
by X, kXcatch and k
X
release are the kinetic catch and release rates of the X−γ complex
formation. For all of the parameter values used in the updated version of the model,
refer to Table 3.1. Our evidence suggests that IFNγ is caught and released by the
cell after it adheres to an as yet unknown molecule on the cell surface. To ease
our parameterization efforts, we coarse-grained this interaction by modeling it as
a single-step process. We stress that the catch and release rates encompass more
than a single on and off rate, though because the exact mechanism of cell entry
and exit is unknown, parameterizing a more biochemically exact model would be
difficult and may not enhance our understanding of the system above that of a
coarse-grained model. Importantly, we show below that our coarse-grained model
is sufficient to account for all of our experimental observations.
To quantify the strength of IFNγ association with cells, we first determined
the IFNγ cell association half-max (IFNγ50). B16 IFNγR KO cells were exposed
to different doses of fluorescent IFNγ for 7 hours, washed extensively and the cell-
captured IFNγ was quantified by flow cytometry. The data were then fitted with
a Hill function with a Hill coefficient of 1, and the IFNγ50 was computed from
the fit (Figure 7.24). To ensure that cell association had reached equilibrium,
we confirmed that the computed IFNγ50 was comparable between cells incubated
with fluorescent IFNγ for 6 and 8 hours (not shown). From this experiment, we
were able to assign a quantitative parameter that represents the strength of IFNγ
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catch-and-release.
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Figure 7.24: Determining the IFNγ50 of IFNγ cell association. B16 IFNγR
KO cells were pulsed with the indicated doses of IFNγ-A647 for 7 hours, then
washed extensively. Cell fluorescence was quantified by flow cytometry and the
resulting data were fit with a Hill function with a coefficient of 1. The IFNγ50 was
computed from the fit. Data plotted are the mean and s.e.m. (errorbars).
We used our model to predict the rate of IFNγ release from the cell. As a model-
ing target, we generated the pSTAT1 profile after removal of exogenous IFNγ from
the system. Phosphorylated STAT1 is an ideal modeling target because it drives
the downstream gene expression in our experiments. The pSTAT1 profile was gen-
erated using our experimentally determined EC50 of signaling (Figure 7.25a). and
the concentration of free IFNγ generated by the model (Figure 7.25b).
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(a) Determining the EC50 of IFNγ
signaling. B16 cells were stimulated
with the indicated dose of IFNγ for
20 minutes. Cells were then fixed and
permeabilized on ice, and stained for
pSTAT1. Fluorescence was quantified
by flow cytometry and the resulting
data were fit with a hill function with a
coefficient of 1.The EC50 was computed
from the fit. Data is representative of at
least 3 independent experiments.
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(b) Model-generated concentration
of free IFNγ. The model generates
a concentration of free IFNγ that de-
creases depending on the rate of endocy-
tosis and cell proliferation. The pSTAT1
profile is generated from the free IFNγ
concentration and the experimentally-
determined EC50 of signaling.
Figure 7.25: Model parameters used to generate the pSTAT1 profile.
We kept IFNγ50 constant and varied the catch and release rates over several
orders of magnitude (Figure 7.26). As a first approximation, we assumed that the
number of IFNγ capture sites was on the same order of magnitude as the number
of IFNγ receptors. We colored some of the plots orange and red because those
pSTAT1 curves closely resembled the curve that we observed experimentally. The
model predicted that IFNγ would have to be released from the cells on a timescale
of several hours. This is somewhat unsurprising given that our evidence suggests
IFNγ is internalized and released. We expect a process where IFNγ enters and
exits the cell to be slower in comparison to canonical biochemical off rates.
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Figure 7.26: Scanning the parameter space of IFNγ-cell catch and release
rates. The model was run by keeping the IFNγ50 constant, while varying the catch
and release rates. The number of IFNγ binding sites on the cell was estimated to be
on the same order of magnitude as the number of IFNγR (103). The pSTAT1 profile
was generated based on the concentration of free IFNγ and the experimentally-
measured EC50 of signaling.
We tested this prediction experimentally by performing a well-mixed compe-
tition experiment. B16 IFNγR KO cells were pulsed with fluorescent IFNγ, and
then the media was replaced with an equimolar concentration of unlabeled IFNγ.
The decay in cell fluorescence was quantified by flow cytometry and the resultant
curve was fit with an exponential decay function (Figure 7.27). The halflife of
IFNγ cell release from the cell is approximately 5h.
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Figure 7.27: Experimental measurement of the IFNγ-cell krelease. B16
IFNγR KO cells were pulsed with 10nM IFNγ-A488 overnight while tumbling in
a large volume of RPMI (in well-mixed conditions). The media was then replaced
with 10nM unlabeled IFNγ and the decay in cell fluorescence was quantified by
flow cytometry. The resultant data were fit with an exponential decay function and
krelease was computed from the fit. Data plotted is representative of 3 independent
experiments.
We then substituted this release rate into our model, and used the IFNγ50 to
infer theIFNγ cell capture rate (IFNγ50 =
krelease
kcatch
). We then fitted this model to
the pSTAT1 data, keeping the number of cell binding sites as a free parameter
(Figure 7.28a). Indeed, the number of association sites calculated per cell (≈
5 × 103) was on the same order of magnitude as the number of IFNγ receptors
(2.5 × 103). Next, we used the pSTAT1 profile generated by the model to plot
the mRNA dynamics and compared this to our data (Figure 7.28b). Using the
experimentally derived IFNγ-cell association and dissociation rates, our model
qualitatively describes the dynamics of pSTAT1 and mRNA.
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(a) Fit of the model to the pSTAT1
data. The experimentally-determined
IFNγ50 and krelease were used to com-
pute the kcatch. These values were then
input into the model and the number
of cell binding sites was kept as a free
parameter. The model qualitatively de-
scribes the data given these parameters.
Data plotted are the mean and s.e.m.
(errorbars).
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(b) Fit of the model to the mRNA
data. The pSTAT1 data was used to
compute the mRNA dynamics. Data
plotted are the mean and s.e.m. (error-
bars).
Figure 7.28: The model qualitatively recapitulates the experimental data.
7.5 Cell surface-exposed phosphatidylserine mediates IFNγ
catch-and-release.
We reasoned that we could eliminate many of the lipid candidates based on their
strength of IFNγ binding (Figure 7.22). Lipid-spotted membranes were probed
with a thousand-fold lower IFNγ concentration (50pM). Indeed, incubating with
a lower concentration of IFNγ constrained the lipids capable of binding to only
three candidates: cardiolipin (CL), phosphatidylserine (PS), and phosphatidyli-
nositol(4)phosphate (PI(4)P) (Figure ??). The remaining lipids bind IFNγ with
a much lower affinity so we did not focus on them as candidate molecules that
mediate catch-and-release signaling.
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Figure 7.29: A lower concentration of IFNγ constrains the lipid candidates
based on their binding affinity. Lipid-spotted strips were incubated with 50pM
IFNγ, then washed and probed with a primary antibody directed against IFNγ. A
secondary HRP-conjugated antibody directed against the primary isotype was then
added and blots were developed and visualized. Code: CL: Cardiolipin; PG: Phos-
phatidylglycerol; PC: Phosphatidylcholine; PE: Phosphatidylethanolamine; PS:
Phosphatidylserine; PA: Phosphatidic acid; DAG: Diacylglycerol; TG: Triglyc-
eride; ST: Sulfatide; SM: Sphingomyelin; Ch: Cholesterol; PI(3,4,5)P3: Phos-
phatidylinositol(3,4,5)Phosphate; PI(4,5)P2: Phosphatidylinositol(4,5)Phosphate;
PI(4)P: Phosphatidylinositol(4)Phosphate; PI: Phosphatidylinositol
In healthy cells, none of the three lipids are typically exposed on the cell surface.
Cardiolipin is sequestered in mitochondrial membranes, while PS and PI(4)P are
primarily localized to the plasma membrane inner leaflet [87]. We stained cells
with lipid-specific reagents and used flow cytometry to detect the presence of these
lipids on the plasma membrane outer leaflet. Specifically, PS was stained using
fluorescently-labeled Annexin V, a protein that specifically binds PS in a CaCl2-
dependent manner. Cardiolipin and PI(4)P were stained with primary antibodies
specific for each lipid and a fluorescently-tagged secondary antibody. As a negative
control, a cohort of cells were stained with the secondary antibodies alone.
While CL and PI(4)P were undetectable, PS was present on the surface of live
(Dapi-) B16 IFNγR KO cells (Figure 7.30). Notably, in fixed and permeabilized
cells, both CL and PI(4)P were readily detectable, indicating that these antibodies
are functional (Figure 7.31). Cardiolipin and PI(4)P were not cell surface-exposed,
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so we eliminated them as candidates for IFNγ binding and focused on PS. PS
typically decorates the plasma membrane inner leaflet, however when cells undergo
apoptosis or necroptosis, PS flips onto the outer leaflet where it acts as an ”eat me”
signal for phagocytes by binding specific receptors present on their surface [21, 53].
Importantly, PS has been observed on the surface of live, viable tumor cells, and on
T cells after T cell receptor-mediated activation [23, 76]. Thus, there are contexts
where PS accumulates on the plasma membrane outer leaflet of live cells. Tumor
expression of PS on the outer leaflet has been suggested to promote metastasis and
may play a role in reducing cell immunogenicity by enhancing phagocytosis, thus
promoting tumor immune-evasion [6, 48].
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Figure 7.30: Live, Dapi- cells express PS on the plasma membrane outer
leaflet. B16 IFNγR KO cells were stained with either: AnnexinV, αCardiolipin,
or αPI(4)P. Dead cells were eliminated by gating cells of interest as Dapi-.
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Figure 7.31: Permeabilization of cells allows staining for intracellular
lipids. B16 IFNγR KO cells were fixed, permeabilized, and stained with either:
αCardiolipin or αPI(4)P.
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We imaged PS on the cell surface using Annexin V, and observed a punctate
pattern similar to that of IFNγ (Figure 7.32a). This staining pattern was distinctly
different than that of a dead cell, where Annexin V brightly stained the entire
plasma membrane on rounded, detached cells (Figure 7.32b).
10 µm 
Annexin V
(a) A. Annexin V assumes a punc-
tate distribution on the surface of
live cells. B16 IFNγR KO cells were
adhered to fibronectin-coated glass bot-
tom culture dishes, then stained with
fluorescently-labeled Annexin V, and
imaged by confocal microscopy. Imag-
ing is representative of at least 3 inde-
pendent experiments.
Dead cell
10 µm 
Annexin V
(b) B. Annexin V brightly stains
dead cells.B16 IFNγR KO cells were
adhered to fibronectin-coated glass bot-
tom culture dishes, then stained with
fluorescently-labeled Annexin V, and
imaged by confocal microscopy. A
rounded, detached cell was identified as
dead.
Figure 7.32: The PS distribution differs markedly between live and dead cells.
Given that cholesterol co-localizes with IFNγ and its depletion reduces IFNγ
cell capture (Figure 7.21), we hypothesized that if PS is the molecule responsible for
binding, it would localize to cholesterol micro-domains. TF-cholesterol was intro-
duced to cells and then imaged with Annexin V on live cells (Figure 7.33). Indeed
Annexin V staining was observed in cholesterol-containing lipid micro-domains.
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Figure 7.33: PS is co-localized with cholesterol. First, TF-cholesterol was
introduced into B16 IFNγR KO cells. TF-MβCD complexes were mixed in PBS
with PBS-washed cells for 5 minutes at 37◦C. Cells were then washed in RPMI and
adhered to fibronectin-coated glass-bottom culture plates. Cells were then stained
with fluorescently-labeled Annexin V and imaged by confocal microscopy.
To show that PS is necessary for IFNγ binding, we tested whether treatment
with Annexin V is capable of blocking IFNγ-binding to PS. Cells were treated with
50nM Annexin V, and then an IFNγ-capture assay was performed (Figure 7.11).
This dose of Annexin V strongly reduced IFNγ cell capture relative to cells treated
with the CaCl2 buffer control (Figure 7.34).
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Figure 7.34: High-dose Annexin V blocks IFNγ cell capture. B16 IFNγR
KO cells were first treated with a high-dose of Annexin V. Specifically, cells were
treated with 50nM Annexin V for 15min at 37◦C. After, cells were kept in An-
nexin V, and 50pM IFNγ diluted in Annexin V-binding buffer supplemented with
3% fetal calf serum (FCS). Data plotted are mean and s.e.m. (errorbars) and
representative of at least 3 independent experiments.
In our experimental settings, it’s unclear what mechanism controls the spa-
tial distribution of phosphatidylserine and cholesterol on the plasma membrane.
The ATP-binding cassette transporter-1 (ABCA-1) plays a role in both cholesterol
and PS lipid bilayer distribution [28, 88]. Therefore one could speculate that the
membrane localization of ABCA-1 explains the co-localization of both cholesterol
and PS. However, one mystery that remains is why the depletion of cholesterol
both transiently, permanently, and at the level of biosynthesis alters IFNγ cell
capture. This result suggests that cholesterol depletion inhibits internalization of
IFNγ. Given the importance of cholesterol for caveolae-mediated endocytosis, we
predict that the importance of cholesterol lies in its ability to serve as a scaffold
for caveolin proteins [57].
The observation that both IFNγ and PS were localized to cholesterol micro-
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domains strongly suggested that they would also co-localized with one another.
We sought to image IFNγ and Annexin V together. To circumvent blocking of
IFNγ by Annexin V, we stained cells with a 50-fold lower dose of Annexin V.
Indeed, IFNγ and Annexin V were nearly super-imposable (Figure 7.35). These
data reveal that PS directly binds IFNγ and is necessary for cell capture of IFNγ.
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Figure 7.35: Low-dose Annexin V permits dual imaging of PS and IFNγ.
B16 IFNγR KO cells were first adhered to fibronectin-treated glass-bottom culture
dishes. Next, cells were treated with a low-dose of Annexin V. Specifically, cells
were treated with a dose of Annexin V titrated down 10-fold from the manufacturer
protocol for 15min at 37◦C. Finally, cells were incubated with IFNγ-A647 for
several hours. Cells were then washed and imaged by confocal microscopy. Imaging
is representative of 2 independent experiments.
We reasoned that the quantity of IFNγ captured by cells would scale positively
with the amount of PS on the cell outer leaflet. To test this, we created three
classes of cells: Live, dying, and dead. Dying cells were made via heat shock, and
cells were killed using staurosporine. These cells were mixed and gated into Dapi
low, medium, and high populations (Figure 7.36). The cells were then stained with
either Dapi and Annexin V, or Dapi and IFNγ-A647. Indeed, populations with
greater PS staining also exhibited increased IFNγ cell association.
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Figure 7.36: Dead and dying cells bind increased IFNγ. B16 IFNγR KO
cells were split into 3 fractions, live, dying, and dead cells. After trypsinizing
and washing cells from culture, approximately 95% are live, as assessed by Dapi
exclusion. Dying cells were generated by heat shocking live cells for 30s in a
water bath set at 42◦C. Dead cells were generated by treating live cells with 5µM
staurosporine for 2 hours at 37◦C. The 3 cell fractions were mixed and immediately
split into 2 staining groups. One group was stained with Dapi and the manufacturer
suggested concentration of Annexin V. The other group was stained with Dapi
and IFNγ-A647. Fluorescence was determined by flow cytometry. Cells were
gated based on their level of Dapi incorporation as live (Dapilo), dying (Dapimed),
and dead (Dapihi). The graph on the right shows the population geometric mean
fluorescence for each gate, and the population spread (errorbars).
Given that IFNγ binds to PS, we decided to check whether the panel of cell lines
tested earlier also present PS on their plasma membrane outer leaflet. We stained
CH12, Hek293T, RAW, H460, and Mel2 with fluorescently-labeled Annexin V and
Dapi. In all cell lines, Dapihi cells stained very brightly with Annexin V (data not
shown). However, when we gated on live cells (Dapilo), we observed that all of the
cell lines presented PS on their outer membrane (Figure 7.37). This observation
is consistent with results from our earlier experiments (Figure 7.8b).
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Figure 7.37: Live cells of diverse origin present PS on the plasma mem-
brane outer membrane. All of the indicated cell lines were stained with Annexin
V-A488 according to manufacturer instructions.
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CHAPTER 8
FUNCTIONAL CONSEQUENCES FOR CATCH-AND-RELEASE
COMMUNICATION
8.1 Catch-and-release communication could enable com-
munication between spatio-temporally separate cells.
In a lymphoid or tumor environment, T cells produce IFNγ for only a short period
of time before disengaging and migrating elsewhere [32, 34, 35]. However, if IFNγ is
caught by cells in the vicinity where it was produced, its strikingly slow release time
could permit signaling to different cell types, which migrate into the environment
later (Figure 8.1). Thus cells that are separated by both space and time could
communicate using cytokine catch-and-release. Macrophages typically recognize
PS via specific receptors, enabling phagocytosis of the PS+ cell [21, 53]. Catch-
and-release signaling may be a mechanism by which T cells deposit cytokines on
PS+ cells in order to communicate with phagocytes that encounter the cell later.
We sought to test whether the IFNγ bound to PS on tumor cells was sufficient to
activate macrophages.
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Figure 8.1: Catch-and-release signaling could enable communication be-
tween spatio-temporally separate cells. In a tumor environment, activated
T cells produce IFNγ for only about 5 hours before dissociating and migrating
elsewhere. However, if IFNγ is sequestered by surrounding tumor cells, its lifetime
in the environment is dramatically lengthened. This would allow it to continue
signaling to tumor cells, and potentially to another cell type that migrated into
the environment later. For instance, if a macrophage migrated to the area later,
it may be able to respond to residual IFNγ, become activated and possibly pro-
duce new cytokines like tumor necrosis factorα (TNFα). Hence the T cell and the
macrophage were never in the same place at the same time, but they are still able
to communicate.
To this end, we further developed our original IFNγ sensor cell assay. As IFNγ-
pulsed cells, we used B16 IFNγR KO melanoma cells. As sensors, we used either
BALB/c wild type (WT), or IFNγR KO murine bone marrow-derived macrophages
(BMDM). We chose B16 IFNγR KO cells as cytokine-sharing cells to avoid poten-
tially confounding effects due to production of inflammatory cytokines by WT B16
cells in response to IFNγ. To generate BMDM, bone marrow was harvested from
the hind femurs and tibia of BALB/c WT or IFNγR KO mice. Bone marrow was
washed, and differentiated for 7 days in teflon bags in the presence of 10ng/mL
mouse M-CSF. Media and cytokines were refreshed every 2 days. After 7 days,
approximately 50% of the bone marrow derived cells were CD11b+ (not shown).
Melanoma cells were pulsed with 10nM IFNγ for 5h, then washed and co-
cultured with either WT or IFNγR KO BMDM. We quantified the response
to IFNγ by expression of inducible Nitric Oxide Synthase (iNOS), a canonical
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macrophage response to the cytokine (Figure 8.2a). Macrophage expression of
iNOS enables their production of reactive nitrogen species, which facilitate killing
of engulfed, intracellular pathogens.
IFNγ-pulsed melanoma cells up-regulated macrophage expression of iNOS in
WT but not IFNγR KO BMDM (Figure 8.2b). Therefore, PS-bound IFNγ is
sufficient to activate macrophages.
(a) Melanoma-Macrophage co-
culture experimental diagram.
B16 IFNγR KO cells were pulsed with
10nM IFNγ or mock-pulsed for 5h,
then washed extensively. Pulsed or
un-pulsed cells were then co-cultured
with day 7, WT or IFNγR KO BMDM
for 1 day.
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(b) IFNγ shared by melanoma
cells is sufficient to activate
macrophages. After 1 day of co-
culture, cells were harvested using ice
cold 5mM EDTA in PBS and gentle
agitation. Cells were fixed, perme-
abilized, and then stained for CD11b
and iNOS. Fluorescence was quantified
by flow cytometry. Data plotted is
the mean and s.e.m. (error bars) and
representative of at least 3 independent
experiments.
Figure 8.2: IFNγ shared by melanoma cells is sufficient to activate macrophages.
Next, dual administration of IFNγ and tumor necrosis factorα (TNFα) are
known to cooperatively induce cell death [8, 50]. Therefore, we asked if cytokine
catch-and-release could enhance cell death in response to sequential treatment
with these cytokines. B16 WT cells were pulsed with IFNγ, and then washed.
After washing, one cohort of cells was left untreated, one was incubated with
TNFα, and the final cohort was incubated with TNFα and neutralizing antibodies
directed against IFNγ (Figure 8.3a). After 24 hours, cell death was quantified by
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Dapi incorporation. Indeed, in conditions where catch-and-release signaling was
permitted, TNFα boosted cell death (Figure 8.3b). This experiment illustrates
an additional functional consequence for catch-and-release signaling: staggered
response to IFNγ and TNFα can enhance cytotoxicity due to the slow release of
IFNγ.
(a) A. Staggered IFNγ TNFα treat-
ment experimental diagram. B16
WT cells were pulsed with 10nM IFNγ
or mock-pulsed for 7h, then washed ex-
tensively. After washing, one cohort of
IFNγ pulsed cells were cultured with
only 10nM TNFα or 10nM TNFα and
neutralizing antibodies directed against
IFNγ. Cell death was quantified after 1
day of culture.
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(b) B. Catch-and-release signal-
ing boosts subsequent TNFα-
mediated killing. After 1 day of cul-
ture, B16 viability was quantified by in-
corporation of Dapi. Data plotted is the
mean and s.e.m. (errorbars) and repre-
sentative of 2 independent experiments.
Figure 8.3: Catch-and-release signaling boosts subsequent TNFα-mediated killing.
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CHAPTER 9
TESTING WHETHER CYTOKINE CATCH-AND-RELEASE IS
APPLICABLE TO OTHER CYTOKINES
Finally, we sought to determine whether other cytokines can also bind to PS. To
this end, we performed a lipid blot experiment using 5nM of the following cytokines:
Interleukin-2 (IL2), Interleukin-4 (IL4), Interleukin-6 (IL6), Interleukin-10 (IL10),
Interleukin-12 (IL12), Interleukin 23 (IL23), Interleukin 17 (IL17) and TNFα. We
chose this concentration of cytokine because it is a dose that may reasonably
accumulate depending on conditions in vivo. We observed that none of these
cytokines bound to any of the lipids spotted onto the strips, with the exception of
IL12 and IL23 (and data not shown), (Figure 9.1, Figure 9.2). We observed binding
to a similar collection of lipids as IFNγ: cardiolipin, sulfatide, phosphatidylserine,
and phosphatidylinositol(4)phosphate. Importantly, both IL12 and IL23 obviously
interacted most strongly with PS.
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Figure 9.1: IL23 binds to a variety of anionic phospholipids. A lipid
spotted strip was blocked, then exposed to 5nM IL23 overnight at 4◦C. Next,
blot were washed then probed with a primary antibody directed against IL23,
a secondary antibody directed against Rat, and developed using HRP sub-
strate. Blot was exposed for 5 minutes before developing. Blot is representa-
tive of 2 independent experiments. Code: CL: Cardiolipin; PG: Phosphatidyl-
glycerol; PC: Phosphatidylcholine; PE: Phosphatidylethanolamine; PS: Phos-
phatidylserine; PA: Phosphatidic acid; DAG: Diacylglycerol; TG: Triglyceride;
ST: Sulfatide; SM: Sphingomyelin; Ch: Cholesterol; PI(3,4,5)P3: Phosphatidyli-
nositol(3,4,5)Phosphate; PI(4,5)P2: Phosphatidylinositol(4,5)Phosphate; PI(4)P:
Phosphatidylinositol(4)Phosphate; PI: Phosphatidylinositol
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Figure 9.2: IL12 binds binds to a variety of anionic phospholipids. A
lipid spotted strip was blocked, then exposed to 5nM IL12 overnight at 4◦C.
Next, blot were washed then probed with a primary antibody directed against
IL12, a secondary antibody directed against Rat, and developed using HRP sub-
strate. Blot was exposed for 5 minutes before developing. Blot is representa-
tive of 2 independent experiments. Code: CL: Cardiolipin; PG: Phosphatidyl-
glycerol; PC: Phosphatidylcholine; PE: Phosphatidylethanolamine; PS: Phos-
phatidylserine; PA: Phosphatidic acid; DAG: Diacylglycerol; TG: Triglyceride;
ST: Sulfatide; SM: Sphingomyelin; Ch: Cholesterol; PI(3,4,5)P3: Phosphatidyli-
nositol(3,4,5)Phosphate; PI(4,5)P2: Phosphatidylinositol(4,5)Phosphate; PI(4)P:
Phosphatidylinositol(4)Phosphate; PI: Phosphatidylinositol
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These data suggest that catch-and-release signaling is likely not distinctive of
IFNγ, but may be applicable to other cytokines, chemokines, and growth factors.
We next tested whether, similar to IFNγ, IL12 could also bind to cells in a PS-
dependent manner. To this end, we repeated the cytokine capture assay using
IL12 (Figure 7.11). B16 IFNγR KO cells were treated with 50nM Annexin V, and
then an IL12-capture assay was performed with IL12 added at 50pM. This dose
of Annexin V strongly reduced IL12 cell capture relative to cells treated with the
CaCl2 buffer control (Figure 9.3).
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Figure 9.3: IL12 also binds to cells in a PS-dependent manner. B16 IFNγR
KO cells were first treated with a high-dose of Annexin V. Specifically, cells were
treated with 50nM Annexin V for 15min at 37◦C. After, cells were kept in Annexin
V, and 50pM IL12 was diluted in Annexin V-binding buffer supplemented with 3%
fetal calf serum (FCS). Depletion of IL12 from the media was quantified by bead-
based ELISA. Data plotted are the mean and s.e.m. (errorbars) and representative
of 3 independent experiments.
Finally, we tested whether IL12 can participate in catch-and-release commu-
nication. Since IL12 can potentiate IFNγ release by macrophages, we assayed
whether IL12 shared from B16 cells results in macrophage secretion of IFNγ. B16
IFNγR KO cells were pulsed with 10nM IL12 for 5h, then washed. B16 cells were
then co-cultured with BMDM for 1 day. Supernatant was harvested after 1 day
of co-culture and assayed for accumulation of IFNγ. Indeed, when macrophages
were co-cultured with IL12-pulsed B16 cells, they released IFNγ, indicating that
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IL12 can also participate in cytokine catch-and-release (Figure 9.4).
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Figure 9.4: IL12 participates in cytokine catch-and-release. B16 IFNγR
KO cells were pulsed with 10nM IL12 for 5h, then washed. B16 cells were then
co-cultured with BMDM for 1 day. Supernatant was harvested after 1 day of
co-culture and assayed for accumulation of IFNγ by bead-based ELISA. Where
indicated, αIL12 was added to the culture. N.D. stands for ”not detected.” Data
plotted are the mean and s.e.m. (errorbars) and representative of 3 independent
experiments.
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CHAPTER 10
SUMMARY
We discovered a novel mechanism of cell-to-cell communication, which we
named cytokine catch-and-release communication. In this mode of signaling, IFNγ
binds to PS exposed on the plasma membrane outer leaflet, is internalized, and
is then slowly released back to the microenvironment. The halflife of cytokine
release from cells is on the order of 5 hours. Once released, the cytokine signals
to nearby cells in a proximity-dependent manner. This mechanism enables tran-
siently produced cytokines to signal over a timescale much longer than that of
their secretion. The pro-inflammatory cytokine IFNγ is secreted by activated T
cells for 5.9±3.6h [32]. However, catch-and-release communication enabled IFNγ
to act over a timescale of 2-3 days, after cells were initially exposed for only a few
brief hours.
Catch-and-release communication enabled melanoma cells to continue up-regulating
genes in the antigen presentation pathway for several days after their initial ex-
posure to IFNγ. Long-term up-regulation of the antigen presentation pathway
had important downstream consequences for T cell activation. Specifically, by
lengthening the period of enhanced antigen presentation, melanoma cells were sus-
ceptible to T cells for a greater duration of time. In addition, sharing of IFNγ from
melanoma cells was sufficient to activate naive macrophages to up-regulate expres-
sion of genes that promote production of reactive nitrogen species. This experi-
ment suggested that two cells (a cytokine producer cell and a different, cytokine
consumer cell) separated by both space and time may be able to communicate.
Finally, this mechanism enabled enhanced TNFα-mediated killing of IFNγ-pulsed
cells by extending the time period that cells responded to IFNγ.
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Catch-and-release signaling is not unique to mouse or melanoma cells, but
is instead a general feature of diverse cell types including human cells, and cell
lines derived from both primary and tumor cells. Exposure of PS on the plasma
membrane outer leaflet was once thought to be characteristic of dead or dying
cells. However, it is increasingly clear that there are many contexts where PS is
exposed on the outer leaflet in both healthy and cancerous, viable cells [76, 86,
23]. Importantly, the surface distribution of PS on live cells is much different
than that of dead cells. On live cells, PS appears to occupy cholesterol-rich lipid
microdomains and assumes a punctate pattern of staining. In contrast, dead cells
exhibit uniform, bright staining over the entire plasma membrane, indicating the
flip of PS from the inner to outer leaflet [21]. Furthermore, we observed that
the cytokines IL12 and IL23 also binds to both purified PS and to cells in a
PS-dependent manner, suggesting that catch-and-release signaling is likely not
distinctive to IFNγ, but may be applicable to other cytokines, chemokines, and
growth factors.
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CHAPTER 11
DISCUSSION
11.1 Using dynamics, modeling, and perturbation-style bi-
ology to uncover novel mechanisms of gene regulation.
Three specific strategies served as the thrust for our study. First, we tracked the
dynamics of the cell response to an extracellular stimulus at many levels ranging
from transcription factor activation (pSTAT1), to RNA, to protein. This allowed
us to unify our understanding of the IFNγ response at the level of signaling with
downstream functional consequences, such as protein expression. Second, we used
targeted, perturbation-style experiments to test specific hypotheses, parameterize
our mathematical model, and ultimately uncover the mechanism by which catch-
and-release signaling operates.
Of late, tracking the dynamics of RNA or protein on a systems-wide scale has
been an attractive strategy to understand what mechanisms control gene regula-
tion [67, 68, 38]. While this strategy can certainly be informative and has yielded
insights into transcriptional and translational regulation, there are limitations to
what one can infer from what is essentially a single dataset. In addition, when these
studies employ mathematical modeling, it is difficult, if not impossible to appropri-
ately parameterize the model without making un-tested assumptions that may or
may not be true. Oftentimes these datasets are effective at generating hypotheses,
but fall short in following through and rigorously testing those hypotheses. Defini-
tive conclusions and a more sophisticated understanding of the system are gleaned
when projects synthesize systems-scale experiments and experiments designed to
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test specific hypotheses [61, 77, 12].
Third, we used a mathematical model to both test our mechanistic under-
standing of the system and guide subsequent experiments. As datasets continue
to grow in richness and size, mathematical modeling will also become increasingly
necessary to distill key features.
11.2 Implications for cytokine catch-and-release communi-
cation in the immune system.
In vivo, an appropriate immune response relies on temporally coordinated waves
of immune cell migration, activation, and cytokine secretion [52, 11, 19, 41, 40].
Lymphocyte differentiation depends primarily on exposure to specific cytokine
cocktails induced in response to a given pathogen [91]. ”First responder” cells
present at the site of injury or infection generate the first wave of cytokines [9, 4].
Given the transient nature of cytokine production, what mechanisms ensure that
subsequent waves of infiltrating immune cells migrate rapidly enough to access
first-wave cytokines? This question can be answered in part by chemokines, which
guide circulating immune cells to the site of infection in a timely manner [11, 47, 63,
40]. However, cells exhibit variable migratory responses to chemokines, resulting
heterogeneity in the timing of cell arrival. Perhaps catch-and-release signaling
provides a temporal buffer for infiltrating immune cells by extending the duration
over which cytokines persist in the environment. This may be particularly relevant
to T helper-type I differentiation, which relies on sequential positive feedback loops
between IFNγ and IL12 [74].
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Indeed, this type of temporally buffered signal has been observed in other sys-
tems. For example, migrating neutrophils leave chemokine-enriched trails in their
wake [47]. These trails were composed of membranous bits of neutrophil uropods,
which were subsequently scavenged by following T cells. The authors speculated
that this mechanism enabled the chemokine to persist in the environment longer
than it would as a soluble molecule.
11.3 Implications of cytokine catch-and-release communi-
cation for other systems.
Macrophages are polarized towards an inflammatory phenotype by exposure to
pro-inflammatory cytokines, namely IFNγ [56]. Inflammatory macrophages can be
characterized based on their production of cytokines like TNFα and IL6, chemokines
like CCL2, high expression of MHC class II, and expression of enzymes that gen-
erate reactive nitrogen species like iNOS. Inflammatory macrophages are critical
for eradication of pathogens and, in some cases can improve immune-mediated
rejection of tumors. On the other hand, these macrophages can contribute to the
pathophysiology of myriad inflammatory diseases including atherosclerosis, cancer,
and insulin resistance [54].
Atherosclerosis is a driver of heart attack and stroke. An inflammatory circuit
between macrophages and pro-inflammatory cytokines is a key driver of atheroscle-
rosis. In fact, disrupting inflammatory signaling and ablating macrophages often
ameliorates the disease phenotype by slowing the progression of atherosclerotic
plaques. In addition, outer leaflet presentation of PS and defective clearance of
apoptotic/necrotic cells is a hallmark of advanced atherosclerotic plaques. It is
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tempting to speculate that accumulation of IFNγ on PS in the necrotic core of
the plaque could lay an inflammatory foundation that drives macrophage polariza-
tion and exacerbates disease. Furthermore, identification of the peptide moiety of
IFNγ and IL12 that binds PS could enable specific targeting of PS in areas where
the phospholipid is presented at high levels on the plasma membrane outer leaflet,
such as atherosclerotic plaques and tumors. This may be an effective strategy for
drug delivery.
11.4 Structural considerations of cytokine-PS interactions.
What biophysical characteristics enable binding of IFNγ, IL12, and IL23 to PS and
can we speculate about this biochemistry to explore other possible protein-lipid
interactions? Our experiments revealed that all three cytokines bind to phospho-
lipids with negatively charged head groups, such as PS, cardiolipin, and phos-
phatidylinositol(4)phosphate. This suggests that a positively charged, polybasic
region of the cytokine mediates binding. Examination of IFNγ structure revealed
a sequence of exposed, cationic domains rich in arginine and lysine residues in
the carboxy terminus [72]. Indeed, this region of IFNγ has proven essential for
electrostatic interaction with negatively charged regions of the glycosaminoglycan
heparan sulfate. IL12 and IL23 also contains a sequence of basic amino acids near
the carboxy terminus of the p40 subunit [89]. Similarly, the bacterial endolysin
PlyC binds strongly to PS via a cationic region of the protein rich in arginines
and lysines [79]. In this study the authors discovered that PlyC first binds PS
via cationic residues and is then internalized. While they were unable to decipher
the specific mechanism of internalization, they did determine that internalization
is cholesterol-dependent. We also observed an important role for cholesterol in
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mediating association of IFNγ with cells.
The study of protein-lipid interactions has been relatively limited compared
to protein-protein interactions, due largely to technical challenges and a dearth
of experimental tools. The importance of developing new tools to characterize
protein-lipid interactions is underscored by increasing evidence describing how
these interactions modify protein function. From a clinical perspective, an un-
derstanding of the key amino acid residues and structural conformation necessary
for protein-PS binding could enable the rational design of PS-targeting peptides.
This may be valuable given the recent interest in developing monoclonal antibod-
ies designed to target tumor cell plasma membrane-expressed PS [69, 26]. On the
other hand, this information could enable prevention of off target effects where a
peptide-based drug is unintentionally sequestered by PS presenting cells.
Sequestration of IFNγ by PS+ cells may be beneficial in some contexts, but
deleterious in others. For example, IFNγ production by activated immune cells in
tumors is often seen as a positive prognostic factor, yet the infusion of recombi-
nant IFNγ in cancer clinical trials has largely failed [90, 49]. Administration of
recombinant IFNγ often leads to significant, debilitating toxicity in the patient.
Perhaps excessively large concentrations of IFNγ accumulate in PS+ tissues, lead-
ing to toxicity. Our discovery that IFNγ binds PS may provide an opportunity
for fresh interpretation of some of the paradoxical results that emerged from the
IFNγ clinical trials.
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CHAPTER 12
FUTURE WORK
12.1 Identify the peptide moiety of IFNγ, IL12, and IL23
responsible for PS binding.
Identification of the specific residues of IFNγ, IL12, and IL23 responsible for PS
binding is an important goal with potentially translational implications. PS is a
phospholipid with a negatively charged head group [87]. Previously, binding of
the bacterial endolysin PlyC to the negatively charged PS head was shown to de-
pend on a sequence of positively charged amino acids [79]. IFNγ has a polybasic
sequence rich in arginine and lysine that is known to mediate electrostatic inter-
action between the cytokine and negatively charged moieties of the glycosamino-
glycan heparan sulfate [72]. In addition, IL12 and IL23 also has a arginine/lysine
rich region near the c-terminus of the p40 subunit [89].
In future work, we will identify the region of IFNγ, IL12, and IL23 necessary
for binding to PS. We will establish a screen using liposomes constructed from a
mixture of phosphatidylcholine and phosphatidylserine. Our lipid blots established
that None of the cytokines bound to phosphatidylcholine. In addition, we will
generate fluorescently-tagged truncations of the IFNγ, IL12, and IL23 proteins.
PS/PC liposomes will be pulsed with dose titrations of fluorescent peptides, then
binding will be quantified by flow cytometry. Once we have identified the peptides
capable of high-affinity binding to PS, we will check their specificity by assessing
PS-specific binding to actual cells.
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12.2 Characterize the mechanism of cytokine internaliza-
tion
We observed that some IFNγ is present on the cell surface or just under the
cell surface, but susceptible to release mediated by low pH treatment. Another
fraction of IFNγ is inside the cytoplasm and resistant to low pH. This indicates
that PS mediates some type of IFNγ internalization. We were unable to block cell
capture of IFNγ by pre-incubating cells with an inhibitor of clathrin and dynamin-
dependent endocytosis, indicating PS-IFNγ internalization is independent of this
pathway.
In other work, PS mediated uptake of the bacterial endolysin PlyC via cholesterol-
rich lipid rafts [79]. The fact that cholesterol and lipid rafts are required for uptake
in both our work and in other work suggests a role for caveolae-dependent endocy-
tosis, which is clathrin-independent [44]. Consistent with some of our results, Shen
et al., were able to rule out other modes of internalization including macropinocy-
tosis and clathrin-dependent endocytosis using drugs that inhibit each pathway.
On the other hand, it is possible that IFNγ is internalized via flipping of PS
from the outer to inner leaflet via a flippase enzyme. Annexin A5, which binds
PS, nanomecanically elicits membrane invagination and formation of small vesicles
that pinch off inside the cell in a form of internalization similar to, but distinct
from macropinocytosis [42].
Taken together, these data suggest that PS-IFNγ internalization occurs via
either caveolae-dependent endocytosis, action of a phospholipid flippase, or non-
canonical pinocytosis similar to that observed for Annexin V. Our result that filipin
inhibits IFNγ catching argues for a role of caveolae because it chelates cholesterol,
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an important component of caveolae-rich microdomains. We will test for the role
of caveolae-dependent internalization by also inhibiting tyrosine kinases involved
in the pathway. Cells will be pre-treated with genistein, an inhibitor of the pro-
tein tyrosine kinases necessary for caveolae-dependent endocytosis, then we will
perform the IFNγ capture assay. We will also stain for Cav1 and observe whether
IFNγ co-localizes with caveolae in lipid microdomains. Finally, we will conjugate
gold nanoparticles to IFNγ and perform transmission electron microscopy to im-
age intracellular movement of IFNγ with greater resolution than that afforded by
fluorescence microscopy.
12.3 Explore catch-and-release signaling in vivo.
What role does catch-and-release signaling play in vivo? This mechanism of signal-
ing lengthens the temporal duration of the cytokine in the microenvironment. We
have initiated a collaboration with the lab of Dr. Raza Zaidi at Temple University
to investigate this in the context of the tumor microenvironment. The Zaidi lab
has evidence that exposure of some tumor cell types to IFNγ actually promotes
lung metastasis (unpublished data). Given the important role of IFNγ in pro-
moting antigen presentation on tumor cells and enhancing T cell recognition, it’s
possible that the pro-metastatic effects of IFNγ extend to the microenvironment
of the tumor, rather than to tumor cells themselves. We will conduct pilot exper-
iments using an intravenous (I.V.) injected melanoma cell line B2905. This cell
line provides an excellent model system because, in contrast to the B16 melanoma
line, it harbors mutations associated with human disease. Our collaborators are
generating a clean IFNγR KO B2905 cell line using the CRISPR/Cas9 system.
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We plan to use these cells to examine the effect of IFNγ shared from cells as
opposed to the effect of IFNγ acting on cells. B2905 WT or IFNγR KO cells
will be pulsed with IFNγ and washed, or pulsed with IFNγ, washed, and acid
stripped to remove cell-associated IFNγ. Then cells will be injected I.V. into mice.
Tumors will be allowed to grow, then lung metastases will be assessed. This system
will allow us to distinguish between the effect that IFNγ may have on promoting
metastasis by acting on tumor cells themselves, versus its potential effect due to
cell-sharing with other cells in the microenvironment.
88
CHAPTER 13
BIBLIOGRAPHY
[1] D. S. Aaronson and C. M. Horvath. A road map for those who don’t know
jak-stat. Science, 296(5573):1653–5, 2002.
[2] S. Agarwal and A. Rao. Modulation of chromatin structure regulates cytokine
gene expression during t cell differentiation. Immunity, 9(6):765–75, 1998.
[3] F. Altare, A. Durandy, D. Lammas, J. F. Emile, S. Lamhamedi, F. Le Deist,
P. Drysdale, E. Jouanguy, R. Doffinger, F. Bernaudin, O. Jeppsson, J. A. Gol-
lob, E. Meinl, A. W. Segal, A. Fischer, D. Kumararatne, and J. L. Casanova.
Impairment of mycobacterial immunity in human interleukin-12 receptor de-
ficiency. Science, 280(5368):1432–5, 1998.
[4] S. Ariotti, M. A. Hogenbirk, F. E. Dijkgraaf, L. L. Visser, M. E. Hoekstra,
J. Y. Song, H. Jacobs, J. B. Haanen, and T. N. Schumacher. T cell memory.
skin-resident memory cd8(+) t cells trigger a state of tissue-wide pathogen
alert. Science, 346(6205):101–5, 2014.
[5] M. Ashburner, C. A. Ball, J. A. Blake, D. Botstein, H. Butler, J. M. Cherry,
A. P. Davis, K. Dolinski, S. S. Dwight, J. T. Eppig, M. A. Harris, D. P.
Hill, L. Issel-Tarver, A. Kasarskis, S. Lewis, J. C. Matese, J. E. Richardson,
M. Ringwald, G. M. Rubin, and G. Sherlock. Gene ontology: tool for the
unification of biology. the gene ontology consortium. Nat Genet, 25(1):25–9,
2000.
[6] A. Bondanza, V. S. Zimmermann, P. Rovere-Querini, J. Turnay, I. E. Du-
mitriu, C. M. Stach, R. E. Voll, U. S. Gaipl, W. Bertling, E. Poschl, J. R.
Kalden, A. A. Manfredi, and M. Herrmann. Inhibition of phosphatidylser-
89
ine recognition heightens the immunogenicity of irradiated lymphoma cells in
vivo. J Exp Med, 200(9):1157–65, 2004.
[7] B. Brooks, D. M. Briggs, N. C. Eastmond, D. G. Fernig, and J. W. Coleman.
Presentation of ifn-gamma to nitric oxide-producing cells: a novel function
for mast cells. J Immunol, 164(2):573–9, 2000.
[8] M. Buntinx, M. Moreels, F. Vandenabeele, I. Lambrichts, J. Raus, P. Steels,
P. Stinissen, and M. Ameloot. Cytokine-induced cell death in human oligo-
dendroglial cell lines: I. synergistic effects of ifn-gamma and tnf-alpha on
apoptosis. J Neurosci Res, 76(6):834–45, 2004.
[9] D. Burzyn, W. Kuswanto, D. Kolodin, J. L. Shadrach, M. Cerletti, Y. Jang,
E. Sefik, T. G. Tan, A. J. Wagers, C. Benoist, and D. Mathis. A special
population of regulatory t cells potentiates muscle repair. Cell, 155(6):1282–
95, 2013.
[10] L. Cai, C. K. Dalal, and M. B. Elowitz. Frequency-modulated nuclear local-
ization bursts coordinate gene regulation. Nature, 455(7212):485–90, 2008.
[11] F. Castellino, A. Y. Huang, G. Altan-Bonnet, S. Stoll, C. Scheinecker, and
R. N. Germain. Chemokines enhance immunity by guiding naive cd8+ t cells
to sites of cd4+ t cell-dendritic cell interaction. Nature, 440(7086):890–5,
2006.
[12] S. H. Chen, W. Forrester, and G. Lahav. Schedule-dependent interaction
between anticancer treatments. Science, 351(6278):1204–8, 2016.
[13] F. Cofano, A. Fassio, G. Cavallo, and S. Landolfo. Binding of murine 125i-
labelled natural interferon-gamma to murine cell receptors. J Gen Virol, 67 (
Pt 6):1205–9, 1986.
90
[14] M. J. de Veer, M. Holko, M. Frevel, E. Walker, S. Der, J. M. Paranjape, R. H.
Silverman, and B. R. G. Williams. Functional classification of interferon-
stimulated genes identified using microarrays. Journal of Leukocyte Biology,
69(6):912–920, 2001.
[15] S. D. Der, A. Zhou, B. R. Williams, and R. H. Silverman. Identification
of genes differentially regulated by interferon alpha, beta, or gamma using
oligonucleotide arrays. Proc Natl Acad Sci U S A, 95(26):15623–8, 1998.
[16] A. S. Dighe, E. Richards, L. J. Old, and R. D. Schreiber. Enhanced in vivo
growth and resistance to rejection of tumor cells expressing dominant negative
ifn gamma receptors. Immunity, 1(6):447–56, 1994.
[17] S. Dubois, J. Mariner, T. A. Waldmann, and Y. Tagaya. Il-15ralpha recycles
and presents il-15 in trans to neighboring cells. Immunity, 17(5):537–47, 2002.
[18] S. Dupuis, E. Jouanguy, S. Al-Hajjar, C. Fieschi, I. Z. Al-Mohsen, S. Al-
Jumaah, K. Yang, A. Chapgier, C. Eidenschenk, P. Eid, A. Al Ghonaium,
H. Tufenkeji, H. Frayha, S. Al-Gazlan, H. Al-Rayes, R. D. Schreiber,
I. Gresser, and J. L. Casanova. Impaired response to interferon-alpha/beta
and lethal viral disease in human stat1 deficiency. Nat Genet, 33(3):388–91,
2003.
[19] J. G. Egen, A. G. Rothfuchs, C. G. Feng, N. Winter, A. Sher, and R. N.
Germain. Macrophage and t cell dynamics during the development and dis-
integration of mycobacterial granulomas. Immunity, 28(2):271–84, 2008.
[20] R. Elkon, E. Zlotorynski, K. I. Zeller, and R. Agami. Major role for mrna
stability in shaping the kinetics of gene induction. BMC Genomics, 11:259,
2010.
91
[21] V. A. Fadok, D. L. Bratton, D. M. Rose, A. Pearson, R. A. Ezekewitz, and
P. M. Henson. A receptor for phosphatidylserine-specific clearance of apop-
totic cells. Nature, 405(6782):85–90, 2000.
[22] M. A. Farrar and R. D. Schreiber. The molecular cell biology of interferon-
gamma and its receptor. Annu Rev Immunol, 11:571–611, 1993.
[23] K. Fischer, S. Voelkl, J. Berger, R. Andreesen, T. Pomorski, and A. Mack-
ensen. Antigen recognition induces phosphatidylserine exposure on the cell
surface of human cd8+ t cells. Blood, 108(13):4094–101, 2006.
[24] K. Gaus, E. Gratton, E. P. Kable, A. S. Jones, I. Gelissen, L. Kritharides, and
W. Jessup. Visualizing lipid structure and raft domains in living cells with
two-photon microscopy. Proc Natl Acad Sci U S A, 100(26):15554–9, 2003.
[25] Consortium Gene Ontology. Gene ontology consortium: going forward. Nu-
cleic Acids Res, 43(Database issue):D1049–56, 2015.
[26] J. Gong, R. Archer, M. Brown, S. Fisher, C. Chang, M. Peacock, C. Hughes,
and B. Freimark. Measuring response to therapy by near-infrared imaging of
tumors using a phosphatidylserine-targeting antibody fragment. Mol Imaging,
12(4):244–56, 2013.
[27] S. A. Grupp, M. Kalos, D. Barrett, R. Aplenc, D. L. Porter, S. R. Rheingold,
D. T. Teachey, A. Chew, B. Hauck, J. F. Wright, M. C. Milone, B. L. Levine,
and C. H. June. Chimeric antigen receptor-modified t cells for acute lymphoid
leukemia. N Engl J Med, 368(16):1509–18, 2013.
[28] Y. Hamon, C. Broccardo, O. Chambenoit, M. F. Luciani, F. Toti, S. Chaslin,
J. M. Freyssinet, P. F. Devaux, J. McNeish, D. Marguet, and G. Chimini.
92
Abc1 promotes engulfment of apoptotic cells and transbilayer redistribution
of phosphatidylserine. Nat Cell Biol, 2(7):399–406, 2000.
[29] D. Hanahan and R. A. Weinberg. Hallmarks of cancer: the next generation.
Cell, 144(5):646–74, 2011.
[30] S. Hao and D. Baltimore. The stability of mrna influences the temporal order
of the induction of genes encoding inflammatory molecules. Nat Immunol,
10(3):281–8, 2009.
[31] S. Hao and D. Baltimore. Rna splicing regulates the temporal order of tnf-
induced gene expression. Proc Natl Acad Sci U S A, 110(29):11934–9, 2013.
[32] C. Helmstetter, M. Flossdorf, M. Peine, A. Kupz, J. Zhu, A. N. Hegazy, M. A.
Duque-Correa, Q. Zhang, Y. Vainshtein, A. Radbruch, S. H. Kaufmann, W. E.
Paul, T. Hofer, and M. Lohning. Individual t helper cells have a quantitative
cytokine memory. Immunity, 42(1):108–22, 2015.
[33] A. Hoffmann, A. Levchenko, M. L. Scott, and D. Baltimore. The ikappab-
nf-kappab signaling module: temporal control and selective gene activation.
Science, 298(5596):1241–5, 2002.
[34] T. Honda, J. G. Egen, T. Lammermann, W. Kastenmuller, P. Torabi-Parizi,
and R. N. Germain. Tuning of antigen sensitivity by t cell receptor-dependent
negative feedback controls t cell effector function in inflamed tissues. Immu-
nity, 40(2):235–47, 2014.
[35] M. P. Hosking, C. T. Flynn, and J. L. Whitton. Antigen-specific naive cd8+
t cells produce a single pulse of ifn-gamma in vivo within hours of infection,
but without antiviral effect. J Immunol, 193(4):1873–85, 2014.
93
[36] O. Ilnytska, M. Santiana, N. Y. Hsu, W. L. Du, Y. H. Chen, E. G. Viktorova,
G. Belov, A. Brinker, J. Storch, C. Moore, J. L. Dixon, and N. Altan-Bonnet.
Enteroviruses harness the cellular endocytic machinery to remodel the host
cell cholesterol landscape for effective viral replication. Cell Host Microbe,
14(3):281–93, 2013.
[37] E. Jouanguy, F. Altare, S. Lamhamedi, P. Revy, J. F. Emile, M. Newport,
M. Levin, S. Blanche, E. Seboun, A. Fischer, and J. L. Casanova. Interferon-
gamma-receptor deficiency in an infant with fatal bacille calmette-guerin in-
fection. N Engl J Med, 335(26):1956–61, 1996.
[38] M. Jovanovic, M. S. Rooney, P. Mertins, D. Przybylski, N. Chevrier, R. Satija,
E. H. Rodriguez, A. P. Fields, S. Schwartz, R. Raychowdhury, M. R. Mum-
bach, T. Eisenhaure, M. Rabani, D. Gennert, D. Lu, T. Delorey, J. S.
Weissman, S. A. Carr, N. Hacohen, and A. Regev. Immunogenetics. dy-
namic profiling of the protein life cycle in response to pathogens. Science,
347(6226):1259038, 2015.
[39] Q. A. Justman, Z. Serber, Jr. Ferrell, J. E., H. El-Samad, and K. M. Shokat.
Tuning the activation threshold of a kinase network by nested feedback loops.
Science, 324(5926):509–12, 2009.
[40] W. Kastenmuller, M. Brandes, Z. Wang, J. Herz, J. G. Egen, and R. N. Ger-
main. Peripheral prepositioning and local cxcl9 chemokine-mediated guidance
orchestrate rapid memory cd8+ t cell responses in the lymph node. Immunity,
38(3):502–13, 2013.
[41] W. Kastenmuller, P. Torabi-Parizi, N. Subramanian, T. Lammermann, and
R. N. Germain. A spatially-organized multicellular innate immune response
in lymph nodes limits systemic pathogen spread. Cell, 150(6):1235–48, 2012.
94
[42] H. Kenis, H. van Genderen, A. Bennaghmouch, H. A. Rinia, P. Frederik,
J. Narula, L. Hofstra, and C. P. Reutelingsperger. Cell surface-expressed
phosphatidylserine and annexin a5 open a novel portal of cell entry. J Biol
Chem, 279(50):52623–9, 2004.
[43] J. Larkin, V. Chiarion-Sileni, R. Gonzalez, J. J. Grob, C. L. Cowey, C. D.
Lao, D. Schadendorf, R. Dummer, M. Smylie, P. Rutkowski, P. F. Ferrucci,
A. Hill, J. Wagstaff, M. S. Carlino, J. B. Haanen, M. Maio, I. Marquez-
Rodas, G. A. McArthur, P. A. Ascierto, G. V. Long, M. K. Callahan, M. A.
Postow, K. Grossmann, M. Sznol, B. Dreno, L. Bastholt, A. Yang, L. M.
Rollin, C. Horak, F. S. Hodi, and J. D. Wolchok. Combined nivolumab and
ipilimumab or monotherapy in untreated melanoma. N Engl J Med, 373(1):23–
34, 2015.
[44] C. J. Lee, H. R. Lin, C. L. Liao, and Y. L. Lin. Cholesterol effectively blocks
entry of flavivirus. J Virol, 82(13):6470–80, 2008.
[45] M. J. Lee, A. S. Ye, A. K. Gardino, A. M. Heijink, P. K. Sorger, G. MacBeath,
and M. B. Yaffe. Sequential application of anticancer drugs enhances cell death
by rewiring apoptotic signaling networks. Cell, 149(4):780–94, 2012.
[46] R. E. Lee, S. R. Walker, K. Savery, D. A. Frank, and S. Gaudet. Fold change
of nuclear nf-kappab determines tnf-induced transcription in single cells. Mol
Cell, 53(6):867–79, 2014.
[47] K. Lim, Y. M. Hyun, K. Lambert-Emo, T. Capece, S. Bae, R. Miller, D. J.
Topham, and M. Kim. Neutrophil trails guide influenza-specific cd8(+) t cells
in the airways. Science, 349(6252):aaa4352, 2015.
[48] L. G. Lima, R. Chammas, R. Q. Monteiro, M. E. Moreira, and M. A.
95
Barcinski. Tumor-derived microvesicles modulate the establishment of
metastatic melanoma in a phosphatidylserine-dependent manner. Cancer Lett,
283(2):168–75, 2009.
[49] B. E. Lippitz. Cytokine patterns in patients with cancer: a systematic review.
Lancet Oncol, 14(6):e218–28, 2013.
[50] Y. Liu, L. Wang, T. Kikuiri, K. Akiyama, C. Chen, X. Xu, R. Yang, W. Chen,
S. Wang, and S. Shi. Mesenchymal stem cell-based tissue regeneration is
governed by recipient t lymphocytes via ifn-gamma and tnf-alpha. Nat Med,
17(12):1594–601, 2011.
[51] H. Lortat-Jacob and J. A. Grimaud. Interferon-gamma binds to heparan sul-
fate by a cluster of amino acids located in the c-terminal part of the molecule.
FEBS Lett, 280(1):152–4, 1991.
[52] J. M. Lund, L. Hsing, T. T. Pham, and A. Y. Rudensky. Coordination of
early protective immunity to viral infection by regulatory t cells. Science,
320(5880):1220–4, 2008.
[53] M. Miyanishi, K. Tada, M. Koike, Y. Uchiyama, T. Kitamura, and S. Nagata.
Identification of tim4 as a phosphatidylserine receptor. Nature, 450(7168):435–
9, 2007.
[54] K. J. Moore and I. Tabas. Macrophages in the pathogenesis of atherosclerosis.
Cell, 145(3):341–55, 2011.
[55] S. Mostafavi, H. Yoshida, D. Moodley, H. LeBoite, K. Rothamel, T. Raj, C. J.
Ye, N. Chevrier, S. Y. Zhang, T. Feng, M. Lee, J. L. Casanova, J. D. Clark,
M. Hegen, J. B. Telliez, N. Hacohen, P. L. De Jager, A. Regev, D. Mathis,
96
C. Benoist, and Consortium Immunological Genome Project. Parsing the in-
terferon transcriptional network and its disease associations. Cell, 164(3):564–
78, 2016.
[56] P. J. Murray and T. A. Wynn. Protective and pathogenic functions of
macrophage subsets. Nat Rev Immunol, 11(11):723–37, 2011.
[57] I. R. Nabi and P. U. Le. Caveolae/raft-dependent endocytosis. J Cell Biol,
161(4):673–7, 2003.
[58] D. E. Nelson, A. E. Ihekwaba, M. Elliott, J. R. Johnson, C. A. Gibney, B. E.
Foreman, G. Nelson, V. See, C. A. Horton, D. G. Spiller, S. W. Edwards, H. P.
McDowell, J. F. Unitt, E. Sullivan, R. Grimley, N. Benson, D. Broomhead,
D. B. Kell, and M. R. White. Oscillations in nf-kappab signaling control the
dynamics of gene expression. Science, 306(5696):704–8, 2004.
[59] D. P. Noren, W. H. Chou, S. H. Lee, A. A. Qutub, A. Warmflash, D. S. Wag-
ner, A. S. Popel, and A. Levchenko. Endothelial cells decode vegf-mediated
ca2+ signaling patterns to produce distinct functional responses. Sci Signal,
9(416):ra20, 2016.
[60] W. W. Overwijk, M. R. Theoret, S. E. Finkelstein, D. R. Surman, L. A.
de Jong, F. A. Vyth-Dreese, T. A. Dellemijn, P. A. Antony, P. J. Spiess, D. C.
Palmer, D. M. Heimann, C. A. Klebanoff, Z. Yu, L. N. Hwang, L. Feigenbaum,
A. M. Kruisbeek, S. A. Rosenberg, and N. P. Restifo. Tumor regression and
autoimmunity after reversal of a functionally tolerant state of self-reactive
cd8+ t cells. J Exp Med, 198(4):569–80, 2003.
[61] A. L. Paek, J. C. Liu, A. Loewer, W. C. Forrester, and G. Lahav. Cell-to-
97
cell variation in p53 dynamics leads to fractional killing. Cell, 165(3):631–42,
2016.
[62] D. Pincus, A. Aranda-Diaz, I. A. Zuleta, P. Walter, and H. El-Samad. Delayed
ras/pka signaling augments the unfolded protein response. Proc Natl Acad Sci
U S A, 111(41):14800–5, 2014.
[63] B. Piqueras, J. Connolly, H. Freitas, A. K. Palucka, and J. Banchereau. Upon
viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of
distinct chemokines to recruit immune effectors. Blood, 107(7):2613–8, 2006.
[64] D. L. Porter, W. T. Hwang, N. V. Frey, S. F. Lacey, P. A. Shaw, A. W.
Loren, A. Bagg, K. T. Marcucci, A. Shen, V. Gonzalez, D. Ambrose, S. A.
Grupp, A. Chew, Z. Zheng, M. C. Milone, B. L. Levine, J. J. Melenhorst, and
C. H. June. Chimeric antigen receptor t cells persist and induce sustained
remissions in relapsed refractory chronic lymphocytic leukemia. Sci Transl
Med, 7(303):303ra139, 2015.
[65] A. Puel, S. Cypowyj, J. Bustamante, J. F. Wright, L. Liu, H. K. Lim,
M. Migaud, L. Israel, M. Chrabieh, M. Audry, M. Gumbleton, A. Toulon,
C. Bodemer, J. El-Baghdadi, M. Whitters, T. Paradis, J. Brooks, M. Collins,
N. M. Wolfman, S. Al-Muhsen, M. Galicchio, L. Abel, C. Picard, and J. L.
Casanova. Chronic mucocutaneous candidiasis in humans with inborn errors
of interleukin-17 immunity. Science, 332(6025):65–8, 2011.
[66] J. E. Purvis, K. W. Karhohs, C. Mock, E. Batchelor, A. Loewer, and G. Lahav.
p53 dynamics control cell fate. Science, 336(6087):1440–4, 2012.
[67] M. Rabani, J. Z. Levin, L. Fan, X. Adiconis, R. Raychowdhury, M. Garber,
A. Gnirke, C. Nusbaum, N. Hacohen, N. Friedman, I. Amit, and A. Regev.
98
Metabolic labeling of rna uncovers principles of rna production and degrada-
tion dynamics in mammalian cells. Nat Biotechnol, 29(5):436–42, 2011.
[68] M. Rabani, R. Raychowdhury, M. Jovanovic, M. Rooney, D. J. Stumpo,
A. Pauli, N. Hacohen, A. F. Schier, P. J. Blackshear, N. Friedman, I. Amit,
and A. Regev. High-resolution sequencing and modeling identifies distinct
dynamic rna regulatory strategies. Cell, 159(7):1698–710, 2014.
[69] S. Ran, A. Downes, and P. E. Thorpe. Increased exposure of anionic phos-
pholipids on the surface of tumor blood vessels. Cancer Res, 62(21):6132–40,
2002.
[70] M. Rusnati, C. Urbinati, E. Tanghetti, P. Dell’Era, H. Lortat-Jacob, and
M. Presta. Cell membrane gm1 ganglioside is a functional coreceptor for
fibroblast growth factor 2. Proc Natl Acad Sci U S A, 99(7):4367–72, 2002.
[71] R. Sadir, E. Forest, and H. Lortat-Jacob. The heparan sulfate binding se-
quence of interferon-gamma increased the on rate of the interferon-gamma-
interferon-gamma receptor complex formation. J Biol Chem, 273(18):10919–
25, 1998.
[72] E. Saesen, S. Sarrazin, C. Laguri, R. Sadir, D. Maurin, A. Thomas, A. Imberty,
and H. Lortat-Jacob. Insights into the mechanism by which interferon-gamma
basic amino acid clusters mediate protein binding to heparan sulfate. J Am
Chem Soc, 135(25):9384–90, 2013.
[73] K. Schroder, P. J. Hertzog, T. Ravasi, and D. A. Hume. Interferon-gamma: an
overview of signals, mechanisms and functions. J Leukoc Biol, 75(2):163–89,
2004.
99
[74] E. G. Schulz, L. Mariani, A. Radbruch, and T. Hofer. Sequential polariza-
tion and imprinting of type 1 t helper lymphocytes by interferon-gamma and
interleukin-12. Immunity, 30(5):673–83, 2009.
[75] B. Schwanhausser, D. Busse, N. Li, G. Dittmar, J. Schuchhardt, J. Wolf,
W. Chen, and M. Selbach. Global quantification of mammalian gene expres-
sion control. Nature, 473(7347):337–42, 2011.
[76] K. Segawa, J. Suzuki, and S. Nagata. Constitutive exposure of phos-
phatidylserine on viable cells. Proc Natl Acad Sci U S A, 108(48):19246–51,
2011.
[77] A. K. Shalek, R. Satija, J. Shuga, J. J. Trombetta, D. Gennert, D. Lu,
P. Chen, R. S. Gertner, J. T. Gaublomme, N. Yosef, S. Schwartz, B. Fowler,
S. Weaver, J. Wang, X. Wang, R. Ding, R. Raychowdhury, N. Friedman,
N. Hacohen, H. Park, A. P. May, and A. Regev. Single-cell rna-seq reveals
dynamic paracrine control of cellular variation. Nature, 510(7505):363–9, 2014.
[78] V. Shankaran, H. Ikeda, A. T. Bruce, J. M. White, P. E. Swanson, L. J. Old,
and R. D. Schreiber. Ifngamma and lymphocytes prevent primary tumour
development and shape tumour immunogenicity. Nature, 410(6832):1107–11,
2001.
[79] Y. Shen, M. Barros, T. Vennemann, D. T. Gallagher, Y. Yin, S. B. Linden,
R. D. Heselpoth, D. J. Spencer, D. M. Donovan, J. Moult, V. A. Fischetti,
F. Heinrich, M. Losche, and D. C. Nelson. A bacteriophage endolysin that
eliminates intracellular streptococci. Elife, 5, 2016.
[80] K. Simons and D. Toomre. Lipid rafts and signal transduction. Nat Rev Mol
Cell Biol, 1(1):31–9, 2000.
100
[81] A. Snyder, V. Makarov, T. Merghoub, J. Yuan, J. M. Zaretsky, A. Desrichard,
L. A. Walsh, M. A. Postow, P. Wong, T. S. Ho, T. J. Hollmann, C. Bruggeman,
K. Kannan, Y. Li, C. Elipenahli, C. Liu, C. T. Harbison, L. Wang, A. Ribas,
J. D. Wolchok, and T. A. Chan. Genetic basis for clinical response to ctla-4
blockade in melanoma. N Engl J Med, 371(23):2189–99, 2014.
[82] M. H. Sung, N. Li, Q. Lao, R. A. Gottschalk, G. L. Hager, and I. D.
Fraser. Switching of the relative dominance between feedback mechanisms in
lipopolysaccharide-induced nf-kappab signaling. Sci Signal, 7(308):ra6, 2014.
[83] H. Suzuki, J. A. Punt, L. G. Granger, and A. Singer. Asymmetric signaling
requirements for thymocyte commitment to the cd4+ versus cd8+ t cell lin-
eages: a new perspective on thymic commitment and selection. Immunity,
2(4):413–25, 1995.
[84] S. Tavazoie, J. D. Hughes, M. J. Campbell, R. J. Cho, and G. M. Church. Sys-
tematic determination of genetic network architecture. Nat Genet, 22(3):281–
5, 1999.
[85] S. Tay, J. J. Hughey, T. K. Lee, T. Lipniacki, S. R. Quake, and M. W.
Covert. Single-cell nf-kappab dynamics reveal digital activation and analogue
information processing. Nature, 466(7303):267–71, 2010.
[86] S. M. van den Eijnde, M. J. van den Hoff, C. P. Reutelingsperger, W. L. van
Heerde, M. E. Henfling, C. Vermeij-Keers, B. Schutte, M. Borgers, and F. C.
Ramaekers. Transient expression of phosphatidylserine at cell-cell contact
areas is required for myotube formation. J Cell Sci, 114(Pt 20):3631–42,
2001.
101
[87] G. van Meer, D. R. Voelker, and G. W. Feigenson. Membrane lipids: where
they are and how they behave. Nat Rev Mol Cell Biol, 9(2):112–24, 2008.
[88] N. Wang, D. L. Silver, C. Thiele, and A. R. Tall. Atp-binding cassette trans-
porter a1 (abca1) functions as a cholesterol eﬄux regulatory protein. J Biol
Chem, 276(26):23742–7, 2001.
[89] S. F. Wolf, P. A. Temple, M. Kobayashi, D. Young, M. Dicig, L. Lowe,
R. Dzialo, L. Fitz, C. Ferenz, R. M. Hewick, and et al. Cloning of cdna
for natural killer cell stimulatory factor, a heterodimeric cytokine with mul-
tiple biologic effects on t and natural killer cells. J Immunol, 146(9):3074–81,
1991.
[90] M. R. Zaidi and G. Merlino. The two faces of interferon-gamma in cancer.
Clin Cancer Res, 17(19):6118–24, 2011.
[91] J. Zhu, H. Yamane, and W. E. Paul. Differentiation of effector cd4 t cell
populations (*). Annu Rev Immunol, 28:445–89, 2010.
102
